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CHAPTER 1 
INTRODUCTION [1-23] 
 Diabetes is a chronic disease that occurs either when the pancreas does not produce 
enough insulin or when the body cannot effectively use the insulin it produces. Insulin is a 
hormone that regulates the blood sugar. Hyperglycemia, or raised blood sugar, is a common 
effect of uncontrolled diabetes and overtime leads to serious damage to different organs of 
the body, especially the eyes, kidneys, nerves, heart and blood vessels. Diabetes is one of the 
most prevalent diseases in the world. Diabetes has emerged as a major health care problem in 
India. 
TYPES OF DIABETES  
 There are three types of diabetes namely Type 1 diabetes, Type II diabetes and 
Gestational diabetes. The Type I diabetes results when the body fails to produce insulin and 
hence requires the administration of insulin injection. The Type II diabetes results when the 
pancreas does not produce enough insulin or the cells not responding to insulin. Gestational 
diabetes results when the body of a pregnant woman does not secrete excess insulin required 
during pregnancy. The percentage of human beings affected by diabetes is shown in Fig. 1. 
Fig. 1:  Pie-chart representation of diabetes 
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‘DIABETES CAPITAL’ tag a burden on India’s heart 
 Diabetes Atlas published by International Diabetes Federation (IDF), estimated that 40 
million persons with diabetes in India in 2007 and this number is predicted to rise 70 million 
people by 2025.The countries with largest number of diabetic people will be India and China. 
World Health Organization has predicted that, India will be the world’s diabetes capital by 
2025.It is gradually becoming more dangerous than AIDS.There is an ample evidence to 
suggest that preventive measures to reduce the burden of diabetes are needed.[4,5] 
ALLOPATHIC DRUGS USED IN DIABETES 
 As diabetes is a multifactorial disease leading to several complications, and therefore 
demands a multiple therapeutic approach. For example, to manage post-prandial 
hyperglycemia at digestive level, glucosidase inhibitors such as acarbose, miglitol and 
voglibose are used. These inhibit degradation of carbohydrates thereby reducing the glucose 
absorption by the cells. To enhance glucose uptake by peripheral cells biguanides such as 
metformin is used. Sulphonylureas like glibenclamide is insulinotropic and works as 
secretogogue for pancreatic cells.  
Limitation of allopathic drugs 
 The limitations of allopathic drugs include taking the medicines throughout life time, 
high cost of medicines, side effects such as hypoglycemia, weight gain, gastrointestinal 
disturbances and liver toxicity etc. should be taking the medicine throughout the life. 
HERBALS USED IN DIABETES[6] 
 Medicinal plants are being looked up for the treatment of diabetes. Many conventional 
drugs have been derived from prototypic molecules in medicinal plants. Metformin 
exemplifies an efficacious oral glucose-lowering agent. Its development was based on the use 
of Galegaofficinalis to treat diabetes. Galegaofficinalis is rich in guanidine, the 
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hypoglycemic component. Because guanidine is too toxic for clinical use, the alkyl 
biguanidessynthalin A and synthalin B were introduced as oral anti-diabetic agents in Europe 
in the 1920s but were discontinued after insulin became more widely available. However, 
experience with guanidine and biguanides prompted the development of metformin.  
 To date, over 400 traditional plant treatments for diabetes have been reported, 
although only a small number of these have received scientific and medical evaluation to 
assess their efficacy. Some of the common plants used for their antidiabetic potential are 
listed in Table 1. [7,8] 
Table 1: Indian medicinal plants with antidiabetic 
and related beneficial effects 
 
Plant Name Ayurvedic/common 
name/herbal 
formulation 
Antidiabetic and other 
beneficial effects in traditional 
medicine 
Annonasquamosa Sugar apple 
Hypoglycemic and 
antihyperglycemic activities of 
ethanolic leaf-extract, Increased 
plasma insulin level 
Artemisia pallens Davana 
Hypoglycemic, increases 
peripheral glucose utilization or 
inhibits glucose reabsorption 
Areca catechu Supari Hypoglycemic 
Beta vulgaris Chukkander 
Increases glucose tolerance in 
OGTT 
Boerhaviadiffusa Punarnava 
Increase in hexokinase 
activity,decrease in glucose-6-
phosphatase and fructose bis-
phosphatase activity, increase 
plasma insulin level, antioxidant 
Bombaxceiba Semul Hypoglycemic 
Buteamonosperma Palasa Antihyperglycemic 
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Camellia sinensis Tea 
Anti-hyperglycemic activity, 
antioxidant 
Capparisdeciduas Karir or Pinju 
Hypoglycemic, antioxidant, 
hypolipidaemic 
Caesalpiniabonduc
ella 
Sagarghota, Fevernut 
Hypoglycemic, insulin 
secretagogue, hypolipidemic 
Cocciniaindica Bimb or Kanturi Hypoglycemic 
Emblicaofficinalis 
Amla, Dhatriphala, a 
constituent of herbal 
formulation, “Triphala” 
Decreases lipid peroxidation, 
antioxidant, hypoglycemic 
Eugenia uniflora Pitanga 
Hypoglycemic, inhibits lipase 
activity 
Enicostemalittorale Krimihrita 
Increase hexokinase activity, 
Decrease glucose 6-phosphatase 
and fructose 1,6bisphosphatase 
activity. Dose dependent 
hypoglycemic activity 
Ficusbengalenesis Bur Hypoglycemic, antioxidant 
Gymnemasylvestre Gudmar or Merasingi 
Anti-hyperglycemic effect, 
hypolipidemic 
Hemidesmusindicus Anantamul 
Anti snake venom activity, anti-
inflammatory 
Hibiscus rosa-
sinesis 
Gudhal or Jasson 
Initiates insulin release from 
pancreatic beta cells 
Ipomoea batatas Sakkargand Reduces insulin resistance 
Momordicacymbala
ria 
Kadavanchi Hypoglycemic, hypolipidemic 
Murrayakoenigii Curry patta 
Hypoglycemic, increases 
glycogenesis and decreases 
gluconeogenesis and 
glycogenolysis 
Musa sapientum Banana Antihyperglycemic, antioxidant 
Phaseolus vulgaris Hulga, white kidney bean Hypoglycemic, hypolipidemic, 
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inhibit alpha amylase activity, 
antioxidant. Altered level of 
insulin receptor and GLUT-4 
mRNA in skeletal muscle 
Punicagranatum Anar 
Antioxidant, anti-hyperglycemic 
effect 
Salaciareticulata Vairi 
inhibitotory activity against 
sucrase, α-glucosidase inhibitor 
Scopariadulcis Sweet broomweed 
Insulin-secretagogue activity, 
antihyperlipidemic, 
hypoglycemic, antioxidant 
Swertiachirayita Chirata 
Stimulates insulin release from 
islets 
Syzygiumalternifoli
um 
Shahajire 
Hypoglycemic and 
antihyperglycemic 
Terminaliabelerica 
Behada, a constituent of 
“Triphala” 
Antibacterial, hypoglycemic 
Terminaliachebula Hirda Antibacterial, hypoglycemic 
Tinosporacrispa  
Anti-hyperglycemic, stimulates 
insulin release from islets 
Vincarosea Sadabahar 
                                             
Anti-hyperglycemic 
Withaniasomnifera 
Ashvagandha, winter 
cherry 
Hypoglycemic, diuretic and 
hypocholesterolemic 
 
Advantages of herbal medicines 
The advantages of herbal medicines in treatment of diabetes include cheaper cost of 
medicines, available widely and less toxic and have fewer side effects as compared to 
allopathic drugs.All in all, diabetes can be prevented with herbal medicines and herbs are 
efficient and safe to one’s health.  
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The hypoglycemic effect of some herbal extracts has been confirmed in human and 
animal models of type 2 diabetes. The World Health Organization Expert Committee on 
diabetes has recommended that traditional medicinal herbs be further investigated. Although 
several therapies are in use for treatment, there are certain limitations in allopathic drugs. 
Although several therapies are in use for treatment, there are certain limitations.Major 
hindrance in amalgamation of herbal medicine in modern medical practices is lack of 
scientific and clinical data proving their efficacy and safety. There is a need for conducting 
clinical research in herbal drugs, developing simple bioassays for biological standardization, 
pharmacological and toxicological evaluation, and developing various animal models for 
toxicity and safety evaluation. 
INSULIN PLANT 
CostuspictusD.Don is commonly known as spiral ginger, belonging to the family 
Costaceae. It is a magical cure of diabetes. Its leaf helps to build up insulin the human body. 
So, it is commonly known as Insulin plant in India. Insulin plant was grown in America and 
is becoming popular in India because of its medicinal value. It is now accepted and used 
widely as an Ayurvedic medicinal herb. 
Consumption of the leaves is believed to lower blood sugar level. Diabetes patients 
are advised to chew two leaves per day in the morning and evening.After one week the 
patient should take one leaf in the morning and evening. This dosage should be continued for 
a month.It is turning out to be munching dietary supplement for diabetes. Allopathic doctors 
too recommend it and it is found to be effective in bringing blood sugar level under complete 
control [9-12]. Many invivo and invitro studies of this Insulin plant are carried out showed that 
this plant is having very potent antidiabetic effect. Though being widely used, no formulation 
containing this plant is available in the market.  The patient feels difficulty in chewing the 
leaves for a month. In order to overcome this and to enhance the oral bio-availability and 
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pharmacological activity, protection from toxicity, physio-chemical degradation, improved 
tissue macrophages, to avoid repeated administration of the dose and to achieve the selective 
or targeted drug delivery towards a specific tissue or organ a attempt is made in this study to 
design and standardize a nano-formulation of Costuspictus. 
INFLUENCE OF NANOPARTICLES IN HERBAL DRUGS 
 Herbal medicines have been widely used all over the world since ancient times and 
have been recognized by physicians and patients for their better therapeutic values as they 
have fewer adverse effects as compared to modern medicines. Phytotherapeutics needs a 
scientific approach to deliver the components in a sustained manner to increase patient 
compliance and avoid repeated administration. This can be achieved by designing Novel 
Drug Delivery System (NDDS) for herbal constituents. NDDS not only reduce the repeated 
administration to overcome non-compliance, but also helps to increase the therapeutic value 
by reducing toxicity and increasing the bio-availability. One such novel approach is 
nanotechnology. Nano-sized drug delivery system of herbal drugs has a potential future for 
enhancing the activity and overcoming the problems associated with plant medicines. Hence, 
integration of the nanocarriers as a NDDS in the traditional medicinal system is essential to 
conflict more chronic diseases like asthma, diabetes, cancer and others.[13-15] 
GREEN SYNTHESIS OF SILVER NANOPARTICLES 
 Biosynthesis of nanoparticles is the active area of research for the last one decade. To 
date, metallic nano-particles are mostly prepared from nobel metals (ie Ag, Pt, Au and Pd), 
among the noble metals, silver (Ag) is the metal of choice in the field of biological system, 
living organisms and medicine[16-18]. Green synthesis of nanoparticles is an emerging branch 
of nanotechnology. Biosynthesis of nanoparticles using plant extracts is the favourite method 
of green, exploited to a vast extent because the plants are widely distributed, easily available, 
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safe to handle and with a range of metabolites and compatibility for pharmaceutical and 
biomedical applications as they do not use toxic chemicals in the synthesis protocols[19, 20]. 
Bio-inspired synthesis of nano-particles provides advancement over chemical and physical 
methods as it is a single step, cost effective and environment friendly and in this method there 
is no need to use high pressure, energy, temperature and toxic chemicals[21, 22, 23]. Types of 
metal nanoparticles and their applications in nanotechnology are depicted in the Fig.3 
Fig.3: Types of metal nanoparticles and their applications in nanotechnology  
 
It is a well-known fact that silver ions and silver-based compounds are highly toxic to 
microorganisms. This aspect of silver makes it an excellent choice for multiple roles in the 
medical field. Silver is generally used in the nitrate form to induce antimicrobial effect. 
ADVANTAGES OF SILVER NANOPARTICLES: 
 Increases the oral bio-availabilty. 
 To overcome the poorly water soluble herbal medicines.
 It decreases the treatment dosage. 
 Prolong action, rapid, single-step, eco-friend method. 
 Non-toxic to the human body. 
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 Have instigated the researchers to investigate mechanism of metal ions uptake and 
bio-reduction by plants, and to understand the possible mechanism of metal 
nanoparticles formation in and by the plants. 
 Green chemistry improves and/or protects our global environment.            
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CHAPTER 2 
REVIEW OF LITERATURE [24-71] 
The chapter provides retrieval of papers both from primary and secondary sources. 
The review of literature encompasses information on pharmacognosy, biological studies and 
phytochemistry of the various species of Costus and the green synthesis of silver 
nanoparticles.  
Rathore AK et al., (1979) have isolated the steroids diosgenin, tigogenin, lanosterol 
and stigmasterol from the undifferentiated callus culture of Costusspeciosus. [24] 
Iwu MM et al., (1981) have a found that the rhizomes of Costusafer contain 
diosgenin (0.8%), stigmasterol (1.5%) and costugenin (3.0%) in addition to 
lanosteroltigogenin and β-sitosterol. The petroleum ether and chloroform extracts of the aerial 
parts yielded 0.12% and 0.16% sapogenin. [25] 
Gupta MM et al., (1981) have isolated two new compounds from the roots of 
Costusspeciosus have been characterized as 24-hydroxy triacontan-27-one and 24-
hydroxytriacontan-26-one by spectral data and chemical studies. Methyl triacontanoate, 
diosgenin and sitosterol have also been isolated and identified. [26] 
Gupta MM et al., (1981) have isolated a new sterol from the roots of 
Costusspeciosus have been characterized as 5 α-stigmast-9(11)-en-3 (β – O) by spectral and 
chemical studies.[27] 
Gupta M et al., (1982) have isolated two new compounds G and H from the 
methanolic leaf extract of roots of Costusspeciosus which have been characterized as 8-
hydroxytriaconjtan-25-one (C30H60O2, mp 95◦) and methyl tritriacontanote (C34 H68 O2,mp 
80-82◦) respectively. [28] 
Singh SB et al. , (1982) have isolated costusoside I (C58H96O27, mp-220-24⁰) and 
costusoside J (C57H94O27.H2O, mp 248-50⁰) from the methanolic extract of the seeds of 
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Costusspeciosus and have been established the structure as 3-O-{β-D-glucopyranosyl (1→2)-
α-L-rhamno-pyranosyl (1→2)-[α-L-rhamno-pyranosyl (1→4)]-β-D-glucopyranosyl-26-O-β-
D-glucopyranosyl-22 α-methoxy-25R)-furost-5-en-3β, 26-diol and its 22-hydroxy compound 
respectively. [29] 
Singh SB et al., (1982) have isolated steroidal saponins from seeds of 
Costusspeciosus and have been elucidated as β–sitosterol-β-D-glucopyranoside, 
prosapogenin-β of dioscin, prosapogenin–A of dioscin, gracillin, 3-O[α-L-rhamnopyranosyl 
((1→2) β-D-glucopyranosyl], 26-O-[β-D-glucopyranosyl]-22 α-methoxy-(25R)-furost-5-en-
3β, 26diol, methyl protodioscin: and protodiosin. [30] 
Iwu MM (1982)have done a survey of phytotherapeutic profile of Nigeria herbs. 32 
plants are used by the tribes in Nigeria for anti-inflammatory and arthritis. Among these, 3 
plants viz., Costusafer, Lonchocarpuscyanescens and Terminaliaivorensis were selected for 
clinical trials and pharmacological test. The pharmacological test was conducted using 
different solvent of the herbs, reduced carrageenin- induced oedema of the rat paw, and 
checked diarrhoea induced by arachidonic acid, castor oil and ameliorated all signs associated 
with adjuvant- induced polyarthritis in rats.[31] 
Suri RK et al., (1986) have isolated six fatty acids viz., palmitic (55.97%), oleic 
(22.75%), linoleic (6.78%), diosgenin (1.91%) and 3 sugars, glucose, galactose and rhamnose 
from the seeds of Costusspeciosus. [32] 
Lin RC et al., (1996) have isolated a new steroidal saponin, aferoside A from the 
roots of Costusafer. Its structure was eatablished as 3-0-{(ߚ-D-apiofuranosyl- (1 to 2)}- ሼߙ-
L-rhamno pyranosyl (1 to 4) β-Dെglucopyranosyl)}-25-(R) spirost-5-en-3β-ol by chemical 
transformation and various spectroscopic methods, mainly 2D NMR techniques (COSY, 
HMQC and HMBC). [33] 
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Lin RC et al., (1997) have isolated two new steroidal saponins, aferosides B (1) and 
C (2), together with the known saponins, dioscin (3) and paraphyllin C (4) from the roots of 
Costusafer. Kaemperol 3-O-ߙ-L-rhamno pyranoside was obtained from the aerial parts of the 
plant. The structure of the new compounds was elucidated principally by 2D NMR spectral 
methods. A structural revision of the sugar sequence was made the previously reported 
saponinaferoside A (6), saponin (1-4) and 6 did not show any ability to potentiate in 
vitrocisplatin cytotoxicity in a human colon cancer lines. [34] 
Souccar C et al., (1997) have evaluated the antiuroliatic activity of Costusspicatus 
(0.5g/kg/day) did not alter the body weight, but reduced the weight of both formed calculi 
and urinary bladder stones respectively, 65% and 48% of control. Treatment of rats with the 
extract of either Cerropiaglazious orCupheabalsamona at doses that reduced the blood 
pressure (0.5g/kg/day) did not affect the animal weight nor did it influence the growth of 
urinary bladder stones. The results showed the possible antiurolithiatic activity of the extract 
of Costusspicatus confirming folkore information. [35] 
Aguiyiet al., (1998) have reported that the aqueous extract of Costusafer leaf and 
stem showed pronounced antibacterial activity against tested micro organisms. The 
observation supports its use in traditional medicine for the treatment of cough and sores. [36] 
Pereira B et al., (1999) have isolated a new furostanol glycoside from the rhizomes 
of Costusspicatus. Its structure was established as (3ߚ, 22ߙ, 25R)-26-(β-D 
glucopyranosyloxy)-22-methoxyfurost-5-en-3-yl-O-D-apio-β-D-furanosyl-(1→2)-O-[6-
deoxy-α-1-mannopyranosyl-(1→4)]β-D-glucopyranoside. The structure was identified using 
1H &13CNMR spectra including 2D NMR spectroscopic technique (COSY, HETCOR & 
COLOC) and chemical conversions. [37] 
Viel TA et al., (1999) have evaluated the antiurolithiatic activity of the aqueous 
extract of Costusspiralis Roscoe in rats. On oral treatment with the aqueous extract (0.25 and 
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0.5g/kg/day) after four weeks surgery reduced the growth of calculi on implants of calcium 
oxalate crystals or zinc disc in the urinary bladder of rats. It did not prevent hypertrophy of 
the organ smooth musculature. The results indicated that the aqueous extract of 
Costusspiralis was endowed with antiurolithiatic activity thus confirming the folklore claim. 
[38] 
Da Silva et al., (1999) have isolated a new steroidal saponin from  the  rhizomes of 
Costusspicatus and its structure was elucidated as ((3ߚ, 22ߙ, 25R)–26-(β–D-                
glucopyranosyloxy)-2-5-en-3-yl-O-D-apio-ߚ-D-furanosyl-(1→4)-O-[ߙ-L-rhamnopyranosyl-
(1→2)] -β-D-glucopyranoside by means of  IR, MS, NMR and chemical evidence.[39]  
Da Silva et al., (2000) have isolated a new flavanoldiglycoside, 3,5-dihydroxy-7,4’-
dimethoxy flavone 3-O-neohesperidoside, together with four known flavonol 3-O-
neohesperidosides from the leaves of Costusspiralis and their structures were elucidated by a 
combination of spectroscopic methods and chemical reactions. [40] 
Da Silva et al., (2000) have isolated two flavonoldiglycosides, tamarixetin 3-O-
neohesperidoside, kaempferide 3-O-neohesperidoside and the known quercetin-3-O- 
neohesperideside together with six other known flavonoids from the leaves of Costusspicatus 
and their structures were elucidated by a combination of spectroscopic and chemical 
methods. The flavanoldiglycosides were evaluated for inhibitory activity of nitric oxide 
production by activated macrophages. [41] 
Indrayanto G et al., (2001) have isolated 3-O-[beta- D-glucopyranosyl- (1”→2’)-β-
D-glucopyranosyl], 27- O-β-D-glucopyranosyl-(25R)-spirost-5-ene-3β, 27-diol from the cell 
suspension cultures of Costusspeciosus, following incubation with diosgenin, and its structure 
was elucidated using a combination of one and two dimension 1H and 13C NMR spectral data, 
positive and negative ions ESMS spectral data. [42] 
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Anagaet al., (2004) have studied the methanolic leaf extract of Costusafer Ker. for 
pharmacological activities in vitro and in vivo. The methanolic leaf extract showed moderate 
local anaesthsetic property, about twice less than lignocaine of the same concentration, on 
guinea pig wheal test. The extract exhibited a biphasic antihyperglycemic activity. At 
200mg/kg body weight, p.o, it decreased the blood glucose level by 50% in streptozocin 
induced hyperglycemia in male rats in 60mins post dosing. However, doses above 200mg/kg 
body weight. p.o caused increase in blood glucose level, potentiating the action of 
streptozocin. At 10µg/mL the extract induced about 98% glucose uptake in differentiated 
3T3–L1 adipocytes when compared with insulin (340nm). [43] 
Behera L.M et al., (2007) have done a survey of some useful medicinal plants against 
gynaecological disorders by the tribes of Ramkhol village forest of Bara Pahad hill range in 
Bargarh district (Orissa). Traditional plants used for the treatment were listed out including 
Costusspeciosus. [44] 
George A et al., (2007) have done the phytochemical analysis of Insulin plant 
(Costuspictus). 18 chemical compounds were identified in the leaves of the plant by using 
GC-MS. From the chromatogram, it was evident that the major component in the ether 
fraction is bis (2’- ethyl hexyl)-1, 2-benzene dicarboxylate (59.04%). The major component 
in the acid fraction are haxadecanoic acid (44.53%) and 4,8,12,16- tetramethylheptadecan 4-
olide (27.86%). [45] 
Jayasri M A et al., (2008) have reported the anti oxidant activity of leaves and 
rhizome of Costuspictus in methanol, aqueous, ethanol and ethyl acetate are assessed using 
different models like DPPH, ߚ-carotene, Deoxy ribose, Super oxide anion, reducing powers 
and metal chelating assay at different concentrations. Total phenolic content showed good 
anti oxidant activity of about 89.5% and 90.0% when compared with standard BHT (85%) at 
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a concentration of 400mcg/ml. Results obtained revealed that methanolic extracts of both 
leaves and rhizomes possess higher anti oxidant activity than other extracts. [46] 
Kosalge SB et al., (2008) have investigated the anthelmintic activity of the aqueous 
extract of Cassia fistula bark (Leguminoseae) (Bahava) andCostusspeciosus rhizomes 
(Zingeberaceae) (Pewda) using earth worms Eiseniafoetida and tapeworm Taeniasaginata as 
test animals. Various concentrations (10-50mg/mL) of plant extracts were tested. Both the 
aqueous extracts showed vermicidal activity and found to be effective as anthelmintic.  [47] 
Sharma V et al., (2009) have demonstrated the anti-cancer potential of the root 
extract of Costusspeciosus. The extract of the root part were screened for in vitro cytotoxicity 
by means of SRB assay on five human cancer cell lines; colon cancer cells (COLO-205, HT-
29, SW-620), liver cancer cells(HEP-2) and prostrate cancer cells (DU-145). All the extracts 
of the plant showed remarkable cytotoxicity effect on each human cancer cell line in the 
range of 70-92%. [48] 
Rajesh et al., (2009) have studied the anti diabetic activity of various extracts of 
Costusspeciosus rhizomes. The anti hyperglycemic activity of petroleum ether, chloroform, 
methanolic and aqueous extracts was evaluated on overnight fasted, streptozotocin(STZ) 
induced diabetic rats. Blood sugar level (BGL) monitored at 0, 30, 60, 12 and 240min 
suggested that all the extracts resulted in reduction of BGL significantly except pet ether 
extract. Aqueous and methanolic extracts reduced initial BGL of 387 to 120mg/dL and 303 to 
161mg/dL respectively at the end of 240min. [49] 
Qari SHM et al., (2009) have studied the genotoxic and anti-genotoxic potential of 
aqueous extract of the rhizomes ofCostusspeciosus using the comet asayswith  three 
concentrations (0.50, 10.0 and 20.0 mg/mL). The human lymphocyte cultures were treated 
for 24h with different concentrations to test for genotoxicity as a single treatment as 
compared to control. The anti-genotoxic effects of the extract were tested in human 
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lymphocyte cultures exposed to the DNA damage inducing agent ethyl methane sulfonate 
(EMS), either alone or combined with the different concentrations of the extract, which was 
added to the cultures before, simultaneously with or after the EMS. The results demonstrated 
that the rhizomes of Costusspeciosus aqueous extract is not genotoxic culture human 
lymphocytes and indicate that when added to lymphocyte cultures with or before the EMS it 
has anti-genotoxic activity against EMS-induced DNA damage. [50] 
RaoValluru J and Mani NS (2009) have carried out the ethnobotanical survey of 
medicinal plants used for the treatment of menstrual problems in SalurMandal of 
Vizianagaram district, A.P, India. Among the 15 plant species, Aristolochiaindica 
(Aristolochiaceae), Costusspeciosus (Costaceae) were most commonly used plant species for 
the treatment of menstural disorder by the tribes.[51] 
Chakraborthy GS et al., (2009) have studied the antibacterial and antifungal activity 
of Costusspeciosus petroleum ether, chloroform, ethyl acetate, ethanol and aqueous extracts 
(Zingiberaceae). The different extracts showed remarkable inhibitory action against various 
gram positive and gram negative bacterial and two fungal species. [52] 
Shubhaand Anusuya D et al., (2010) have reported the anti oxidant and nutrient 
content of micro propagated Costuspictus inoculated with beneficial soil micro organisms. 
The nutrient status of plants inoculated with Glomusfasiculatum, Azetobacter, 
Aspergillusawamori, Frateuriaaurentia and Trichodermavirideshowed appreciable increase 
in total antioxidant content and also enhances the nutrient value of plants. [53] 
Reddy JL et al., (2010) have studied the antibacterial activity of the leaf essential oil 
of Costuspictus against ten bacterial strains by agar well diffusion method. The leaf oil 
exhibited pronounced activity against all the tested micro organisms. [54] 
Quintans LJ et al., (2010) have studied the antinociceptive and anti inflammatory 
effect ofCostusspicatus in experimental animals by using acetic acid, formalin, hot plate test 
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while inflammation was induced by carrageenan. Following oral administration of 
methonolic extract of C. spicatus (100, 200 and 400mg/kg) significantly reduced the number 
of writhes (52.8, 43.1 and 55.3%) respectively in the writhing test and the number of paw 
licks during phase I (61.9, 54.1 and 92.1%) and phase II (62.5, 82.9 and 98.1%, all doses) 
during the formalin test to the control group animals. The reaction time during hot plate was 
significantly increased and was dose-dependent whereas, pretreatment with nalaxone 
rigorously reduced the analgesic potential of methonolic extract of C. spicatus, which 
suggested that participation of opioid system in the modulation of pain induced by 
methonolic extract of C. spicatus. The results unlikely provoked to the motor abnormality, as 
methonolic extract of C. spicatus- treated mice did not show any performance alteration 
during the Rota-rod test. The administration of 200-400mg/kg (i.p) of methonolic extract of 
C. spicatus shows an anti-inflammatory effect during the carragenan test; this was based on 
inference with inflammatory mediator synthesis. The results indicated that the methonolic 
extract of C.spicatus shows significant effect of antinociceptive and anti inflammatory 
actions. [55] 
Britto, R.M et al., (2011) have studied the arterial contractility and investigate its 
M.O.A from the aqueous fraction of Costusspiralis(Jacq.) Roscoe leaf. The aqueous fraction 
effect on the cardiac contractility was studied on isolated electrically driven guinea pig left 
atria. Atropine and tetraethyl ammonium (TEA) were employed to mechanism of aqueous 
fraction. The role of calcium in this effect was also studied by analyzing the aqueous fraction 
effect on the Bowditchth’s phenomenon, as well as by studying whether it could interfere 
with the concentration effect curve for calcium chloride, isopreterenol and BAY K 8644. 
They proposed that the aqueous fraction of Costusspiralis leaf depresses myocardial 
contractility by reducing the L-type calcium current and by decreasing the intra cellular 
calcium transient.[56] 
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Mohamed S et al., (2011) have carried out antituberculosis screening using 
tetrazolinium bromide microplate assay (TEMA) method. The MIC was in the range of 1000 
to 400μg/mL for 38 plant extracts tested. Among these, the methanolic leaf extract of 
Angiopteris erector exhibited the highest activity with MIC of 400μg/mL. Five other extracts, 
namely Costusspeciosus (stem and flowers) and Piper sarmentosum (whole plant), 
Plucheaindica(flower), and Tabernaemontanacoronaria (leaf) exhibited antituberculosis 
activity, each with MIC of 800µg/mL.[57] 
Nadumane VK et al., (2011) have studied the anti proliferative and apoptotic effect 
of Costuspictus D. Don aqueous and alcoholic extracts on fibrosarcoma HT-1080 cell lines. 
Different concentrations of these extracts were evaluated for their cytotoxicity by tryptophan 
blue dye exclusion method and 3-(4,5-dimethyl thiazol-2yl)- 2,5- diphenyltetrazolinium 
bromide (MTT) assay on cancer cell lines (Fibrosarcoma HT-1080) and a normal cell 
line(human peripheral lymphocyte). The apoptotic potential was analyzed by DNA 
fragmentation analysis of the treated cells. The ethanol extract was found to be anti-
proliferative and cytotoxic at lower concentrations and induced cell death in HT-1080 
fibrosarcoma cells. The ethanol extract of C. pictuswas found to be anti-proliferative and 
cytotoxic at lower concentrations and induced cell death in HT-1080 fibrosarcoma cells. The 
ethanol extract at the same concentrations had no cytotoxicity on normal lymphocytes. 
Compared to ethanol extracts, aqueous and methanol extracts were less effective. [58] 
Green synthesis of Silver nanoparticles 
A review of literature on silver nanoparticles of various plants and extracts are 
presented in order to evaluate whether the nanparticles are useful in the reducing the doses 
etc.  
Jain D et al., (2009) have described the green synthesis of silver nanoparticles from 
1mM silver nitratesolution through the extract of papaya fruit as reducing as well as capping 
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agent. Nanoparticles were characterized using UV-visible absorption spectroscopy, FTIR, 
XRD and SEM. X-ray diffraction and SEM analysis showed the average particle size of 
15nm as well revealed their cubic structure. Biologically synthesized silver nanoparticles 
were found to be highly toxic against different multi drug resistant human pathogens. [59] 
Christensen L et al., (2011) have synthesized silver nanoparticles using 
Murrayakoenigiileaf extract and the reported the effect of broth concentration in reduction 
mechanism and particle size. The rapid reduction of silver ions was monitored using UV-
visible spectrophotometry and showed the formation of silver nanoparticles within 
15minutes. Transmission Electron Microscopy and Atomic Force Microscopy analysis 
showed the synthesis of silver nanoparticles is varied from 10-25nm and have the spherical 
shape and the X-Ray Diffraction analysis confirms the nanocrystalline phase of silver with 
FCC crystal structure. It was found that the increasing broth concentration increases the rate 
of reduction and decreases the particle size. [60] 
Manopriya M et al., (2011) have reported the synthesis of silver nanoparticles using 
the leaf extracts of Euphorbia hirtaand Neriumindicum. Synthesized particles are 
characterized by UV – Spectrophotometer, SEM, FTIR and X- ray diffraction analysis. The 
Debye-Scherrer equation was used to calculate particle sizes and the average size of the silver 
nanoparticles synthesized by E.hirtawas 31nm and by N.indicumwas 29nm. Further the 
synthesized silver nanoparticles were tested against common bacterial pathogens.[61]
 Ponaruselvam S et al., (2012) have developed a novel approach for the green 
synthesis of silver nanoparticles using aqueous leaves of Cantharanthusroseus (Linn. G. 
Don) The scanning electron microscopy showed the formation of silver nanoparticles with an 
average size of 35-55nm. X-Ray Diffraction analysis showed that the particles were 
crystalline in nature with the face centered cubic structure of bulk silver nanoparticle with the 
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broad peaks at 32.4, 46.4 and 28.0 respectively. The obtained silver nanoparticles showed the 
antiplasmodial activity against Plasmodium falciparum. [62] 
Firdhouse JM et al., (2012) have synthesized the silver nanoparticles using the 
ethanolic leaves of Pisoniagrandis (R.Br) using three different methods and the completion 
of the reaction was monitored with UV-visible spectrophotometer and characterized using 
XRD, Scherrer’s equation and SEM analysis. The particle size was found to be less than 
150nm, spherical shape as confirmed from SEM and XRD analysis.[63] 
Rajan K et al., (2012) have described the synthesis of gold nanoparticles from the 
methanolic leaf extract of Toona ciliate bark. The synthesized gold nanoparticles showed a 
surface Plasmon band around 55nm when analysed via UV –Visible Spectroscopy, indicated 
the gold nanoparticles of nano dimension (10-9mm). Transmission Electron Microscopy study 
of gold nanoparticles revealed that the particles are spherical, poly dispersed nanoparticles of 
varying sizes ranging from 40-75nm along the encapsulating cage. [64] 
Akl M et al., (2012) have synthesized the silver nanoparticles (AgNPs) of mulberry 
leaves extract at room temperature. Silver nanoparticles were characterized using UV-visible 
absorption spectroscopy, scanning electron microscopy (SEM) and X-ray diffraction (XRD). 
Further, silver nanoparticles showed effective antibacterial activity toward Staphylococcus 
aureusand Shigellasp. [65] 
Pavani KV et al., (2013) have synthesized the silver nanoparticles using methanolic 
extract of flowers of Ipomoea indica.  The formation of silver nanoparticles was confirmed 
by Scanning Electron Microscopy (SEM) and X-Ray Diffraction (XRD) studies. SEM image 
revealed that silver nanoparticles are quite polydispersed, the size ranging from 10nm to 
50nm. The formation of crystalline silver nanoparticles was confirmed using X-ray 
diffraction analysis. [66] 
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Roy K et al., (2013) have demonstrated the synthesis of silver nanoparticles by 
reducing silver nitrate with fruit extract of grape (Vitisvinifera). Characterization of the 
metallic nanoparticles was done by UV- Vis Spectroscopy, Dynamic Light Scattering (DLS) 
and Energy Dispersive X-ray Spectroscopy (EDX). The particle size and lattice image of the 
silver nanoparticles was studied by Transmission Electron Microscopy (TEM). The 
antibacterial activity of these nanoparticles was studied against Bacillus subtilisand 
Escherichia coli. Growth curves of bacteria in presence of silver nanoparticles showed 
inhibition of growth suggesting antibacterial property of the nanoparticles. [67] 
Iravani S et al., (2013) have studied the production of silver nanoparticles using 
Pinuseldaricabark extract and optimization of the biosynthesis process. The effects of 
quantity of extract, substrate concentration, temperature, and pH on the formation of silver 
nanoparticles are studied. TEM images showed that biosynthesized silver nanoparticles 
(approximately in the range of 10–40 nm) were predominantly spherical in shape. The 
preparation of nanostructured silver particles using P. eldaricabark extract provides an 
environmentally friendly option, as compared to currently available chemical and/or physical 
methods.[68] 
Sulaiman GM et al., (2013) have synthesized the silver nanopaticles from leaves 
extract ofEucalyptus chapmaniana and test the antimicrobial of the nanoparticles against 
different pathogenic bacteria, yeast and its toxicity against human promyelocyticleukemia 
(HL-60) cell line. The synthesized silver nanoparticles exhibited a maximum absorption 
peaks at 413 nm due to characteristic surface plasmon resonance. X-Ray Diffraction analysis 
showed that the particles were crystalline in nature with the face centered cubic structure of 
bulk silver nanoparticle with the broad peaks at 38.50◦ and 44.76◦ respectively. The 
synthesized silver nanoparticles efficiently inhibited various pathogenic microorganisms and 
reduced viability of the (HL-60) dose dependent manner. [69] 
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Sivaraman D et al., (2013) have investigated the synthesis and characterization of 
Silver nanoparticles (AgNPs), and their antimicrobial effect on gram positive and gram 
negative bacteria by using hydro alcoholic leaf extract of Ipomoea aquaticaForsk (HAEIA). 
The bio-reduced silver nanoparticles were appropriately characterized by using UV-Vis 
spectroscopy, particle size distribution and zeta potential. The particle size of bio synthesized 
silver nanoparticles is found to be in the range of 77-624 nm with polydspersity index (PDI) 
of 0.207 clearly indicates that the particles are in very narrow size distribution. The zeta 
potential value of 6.16 mV showed that the nanoparticles prepared are stable.[70] 
Yadav SKet al., (2013) havebiosynthesized the silver nanoparticles using different 
solvents of TerminaliachebulaRetz.fruit bodies. They exhibited a maximum absorption peaks 
ranging between 410-430nm due to characteristic surface Plasmon resonance. The spherical 
shaped silver nanoparticles were observed. The antibacterial property of synthesized 
nanoparticles was observed by Agar Well Diffusion method against different clinically 
isolated multi-drug resistant gram positive and gram negative bacteria.[71] 
The review of literature has shown that Costusspecies have potent antidiabetic activity 
and no formulations of the same have been formulated and evaluated. Hence an attempt in 
this dissertation has been made to synthesize silver nanoparticles of the methanolic extract of 
the Costuspictus D. Don and evaluate the same for antidiabetic activity. 
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CHAPTER 3 
AIM AND SCOPE [72-76] 
 
Nanotechnology is one of the most active areas of research in modern material 
science. The rapid development of nanotechnology has opened the possibility of controlling 
and manipulating structures at the molecular level and led to the creation of novel surface 
architectures and materials. Traditional biomedical applications incorporate the use of 
nanotechnology in a broad spectrum of areas. [72] 
The growing of environmental friendly nanoparticles, researchers are using green 
methods for the various metal nanoparticles. Now-a-days, biosynthesis of nanoparticles by 
plant extracts is currently under exploitation. The development of biologically inspired 
experimental processes for the synthesis of nanoparticles is evolved in to an important branch 
of nanotechnology.[73] 
Nanocrystalline silver nanoparticles have found tremendous applications in the field 
of high sensitivity biomolecular detection and diagnostics, antimicrobials and therapeutics. 
Several nano-oriented approaches are being intended in order to optimize the technological 
aspect of the drugs. The use of these processes has dramatically enhances the dissolution 
rates in vitro and bioavailability in vivo of many drugs.[74] 
An attempt is made to enhance the dissolution rates and hence bio-availability and 
furthermore to decrease the treatment dosage of the CostuspictusD. Don extract by preparing 
its silver nanoparticles. The present study is designed to evaluate and compare the effects of 
the methanolic leaf extract of CostuspictusD. Don and its silver nanoparticles.  
The ethno pharmacological studies revealed that the leaves of Costus pictusD. Don 
are having potent anti diabetic activity, diuretic activity, hepatoprotective activity. It is also 
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used to treat rashes, asthma, and bronchitis, reduce fever and to eliminate intestinal worms. 
The plant also possesses analgesic and anti-inflammatory, anti-urolithiatic activity. The 
infusion of this plant is used to treat renal disorder.The leaf essential oil is having 
antibacterial activity. The crude ethanolic extract of this plant possess antiproliferative and 
apoptotic effects. The phytochemical studies of Costus pictusD. Don have reported the 
presence of proteins, carbohydrates, alkaloids, flavonoids, phenolic compounds, tannins, 
saponins. [75, 76] 
Based on the above ethnomedical information and studies available, the present 
research work has been framed to carry out the following studies on the leaves of Costus 
pictus D. Don. 
1. Pharmacognostical studies 
 Macroscopic and microscopic evaluation. 
 Standardization parameters 
 Quantitative analytical parameters 
 Powder microscopy and Fluorescence analysis of powder and extracts. 
2. Phytochemical studies 
 Preliminary phytochemical screening 
 Quantitative estimation of secondary metabolites 
 TLC & HPTLC fingerprint analysis 
3. Synthesis of methanolic leaf extract of Costus pictus D. Don silver 
nanoparticles (MECPAgNP’S) 
4. Characterization of methanolic leaf extract of Costus pictus D. Don silver 
nanoparticles (MECPAgNP’S) 
 Determination of particle size, polydispersity Index & zeta potential. 
 UV-Visible spectroscopical analysis 
                                                                                               Aim and Scope 
 
Department of Pharmacognosy, MMC. 26 
 Morphology of MECPAgNP’s by SEM analysis 
5. Pharmacological studies 
i) In vitro antioxidant activity by 
 Scavenging of 2,2-Diphenyl -1-picrylhydrazyl (DPPH) 
 Scavenging of Hydrogen peroxide 
 Total Antioxidant activity by Phosphomolydenum method 
 Ferric Reducing Antioxidant Power Assay 
 Reducing power assay 
  ii) In vitro antidiabetic activity by 
 Inhibition of alpha amylase enzyme assay 
 Inhibition of alpha glucosidase enzyme assay 
 Glucose uptake in yeast cells 
 Non – enzymatic glycosylation of haemoglobin assay 
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CHAPTER 4 
 
PLANT PROFILE [9-12, 77-79] 
 
 
BIOLOGICAL SOURCE   : CostuspictusD. Don 
 
FAMILY     : Costaceae 
 
SYNONYMS     :Costusheiroglyphica; Costusmexicanus 
      Costuscongestus 
 
SYSTEMATIC POSITION    
 
Rank     : Species  
Domain     : Eukaryota (unranked) 
Kingdom     : Plantae  
Phyllum     : Magnoliophyta 
Class      : Liliopsida 
Order     : Zingeberaceae 
Family     : Costaceae 
Genus     : Costus 
Species     : pictus 
 
VERNACULAR NAMES 
 
English     : Painted spiral ginger; Stepladder ginger;  
Spotted spiral ginger; Insulin plant 
 
Hindi      : Keukand 
Tamil      : Kottam 
Malayalam     : Insulin chedi. 
Marathi      : Pushkarmula 
Sanskrit     : Kemuka 
Gujarati     : Pakarmula 
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DESCRIPTION 
 
Costuspictus is an ornamental plant of Mexico. Itis a relatively new entrant to Kerala. It 
is a perennial herbaceous plant grows up to 3m in height. It is called as Insulin plant because 
it builds up insulin in the human body. The Catch phrase of this plant is “A Leaf a day keeps 
Diabetes away”. 
GEOGRAPHICAL DISTRIBUTION AND OCCURRENCE 
CostuspictusD. Don is distributed along the coast from Mexico to Costa Rica,Beliza, 
Nicarauga, Gautemala, Hondurasand Elsavador.  It is locally known as Cana brava or Cana 
de jabali in Mexico. 
HABIT AND HABITAT  
CostuspictusD. Don is a perennial evergreen herb. It is well grown in part shade to 
part sun, but well grown in full sunlight with adequate water. It will grow in containers and in 
the ground. It requires acidic and neutral soil PH and the soil should be sandy, loamy and 
clay. 
ETHNOMEDICINAL INFORMATIONS FOR WHOLE PLANT:  
(1) In Traditional Medicine it is used to promote longevity, treat rashes, asthma, and 
bronchitis, and reduce feverand to eliminate intestinal worms. 
(2) The leaves are reported to have a potent anti-diabetic activity. The plant also 
possesses analgesic and anti-inflammatory, anti-urolithiatic, diuretic, 
hepatoprotective activity. 
(3) The infusion of this plant is used to treat renal disorder. 
(4) The leaf essential oil is having antibacterial activity. 
(5) The crude ethanolic extract of this plant possess antiproliferative and apoptotic 
effects. 
 
 
 
 
 
PHARMACOGNOSTICAL 
EVALUATION 
 
 
 
 
 Fig.4.HERBARIUM of Costuspictus D. Don 
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CHAPTER - 5 
PHARMACOGNOSTICAL EVALUATION[80-91] 
 
Pharmacognostical study is the preliminary step in the standardization of crude drugs. 
The detailed pharmacognostical evaluation gives valuable information regarding the 
morphology, microscopical and physical characteristics of crude drugs. Pharmacognostic 
studies have been done on many important drugs, and the resulting observations have been 
incorporated in various pharmacopoeias. The pharmacognostic study gives the scientific 
information regarding the purity and quality of crude drugs. [80] 
MATERIALS AND METHODS 
Collection of specimens 
The plant specimens were collected from Dr.Gour, Rock Garden, G. Amsapuram, 
Theni District, Tamil Nadu, India during the month of August 2013. The plant was identified 
and authenticated by Dr. L. Stephen, Lecturer in Botany, American College. The 
authenticated herbarium sheet has been placed at the Dept. of Pharmacognosy, College of 
Pharmacy, Madurai Medical College. A copy of the herbarium has been presented in Fig.4 
special care was taken to select healthy plants and normal organs for macroscopical studies. 
The macroscopical features of the plant are presented in Figs. 5.1 to 5.6. 
SECTION A - MACROSCOPICAL EVALUATION 
Morphology:  Some of these gross morphological characters of drugs such as shape, size, 
margin, apex, venation, are identification features of drugs. These features give valuable 
information about the drugs. 
Cellmorphology:  It includesthe study of morphological characteristics of particular 
cells.The various aerial parts of Costuspictus D. Doncollected for macroscopical evaluation 
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were leaves, flower and cone. The photographic representation of the macroscopic features of 
the plant is shown in Figs. 5.1 to 5.6. 
SECTION B - SENSORY EVALUATION [81] 
The term sensory evaluation refers to organoleptic evaluation. Characters such as 
color, odor, taste, texture, touch etc. are evaluated with the help of sense organs. The sensory 
characteristics of organized as well as unorganized drugs give an idea about the quality, 
identity, purity of drugs.  
SECTION C - MICROSCOPICAL EVALUATION  
Microscopical study of organized crude drugs is an important parameter for 
evaluation. Another important aspect of microscopical evaluation is the study of surface 
constants. These evaluations allow more detailed examination of the phytodrug to identify the 
organized drug by its histological character. It provides detailed information about the crude 
drugs by virtue of its property to magnify the fine structures of minute objects to be 
visualized and thereby confirm the structural details of the plant drugs under evaluation. It 
can also be used in the determination of the optical as well as micro chemical properties of 
the crude drug. 
 The samples of the leaves were cut and removed from the plant and fixed in FAA 
(formalin-5mL + acetic acid-5mL + 70% ethyl alcohol-90mL). After 24h of fixing, the 
specimens were dehydrated with graded series of tertiary-butyl alcohol as per the schedule 
given by Sass, 1940. [82] The infiltration of the specimens was carried by gradual addition of 
paraffin wax (m.p. 58-60°C) until TBA solution attained super saturation. The specimens 
were then cast into paraffin blocks.  
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Sectioning 
            The paraffin embedded specimen was sectioned with the help of rotary microtome. 
The thickness of the sections was 10-12µm, de-waxing of the sections was carried out by 
customary procedure (Johansen, 1940). [83] The sections were then stained with toludine blue 
as per the method published by O’Brien et al. (1964). [84]Toludine blue, a polychromatic stain 
was used for staining as the results were remarkably good; and some cytochemical reactions 
were also obtained. The dye rendered pink colour to the cellulose walls, blue to the lignified 
cells, dark green to suberin, violet to the mucilage, blue to the protein bodies etc. The sections 
were also stained with saffranin and fast-green and iodine wherever necessary. 
Leaf clearing 
Two methods were used for studying the stomatal morphology, venation pattern and 
trichome distribution. Paraffin embedded leaf was used for para-dermal sections. From these 
sections, the epidermal layers as well as vein islets were studied. Another method employed 
was clearing leaf fragments by immersing the material in alcohol (to remove chlorophyll) 
followed by treating with 5% sodium hydroxide. The material was rendered transparent due 
to loss of cell contents. Epidermal peeling by partial maceration employing Jeffrey’s 
maceration was also done. Glycerin mounted temporary preparations were made for cleared 
materials.   
For study of elements of xylem, small fragments of leaves were macerated with 
Jeffery’s maceration fluid.  
Powdered materials of different parts were cleared with sodium hydroxide and 
mounted in glycerin medium after staining. Different cell component were studied and 
measured. 
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Photomicrographs 
The photographs of different magnifications were taken with Nikon lab photo 2 
microscopic units. For normal observations bright field was used and for the study of starch 
grains and lignified cells, polarized light was employed. Since these structures have 
birefringent property, under polarized they appear bright against dark background. The 
magnifications of the anatomical features are indicated by the scale-bars in the photographs.  
The microscopic features of the leaves was presented in (Figs.6.1 to 10.2) 
SECTION D - QUANTITATIVE ANALYTICAL MICROSCOPY 
Quantitative analytical microscopy is useful for the measurement of cell contents of 
the crude drug and thus helps in their identification, characterization and standardization. 
After several numbers of determinations, a clear idea about the identity and characteristic 
features of the drug can be obtained. This method is based on the comparison between the 
characteristics observed in the sample and those standard materials of known origin. 
Determination of Leaf Constants 
 The stomatal number, stomatal index, vein islet number, vein termination number 
were determined on fresh leaves using standard procedures. 
Determination of Stomatal number and Stomatal Index[88] 
 It is a very specific criterion for identification and characterization of leafy crude 
drugs. Four different types of stomata are often available for matured leaves that are 
distinguished by their form and arrangement in the surrounding cells.To study the stomatal 
number and stomatal index of leaf, the leaf was subjected to epidermal peeling. 
Stomatal number 
 Stomatal number is the average number of stomata per square mm of epidermis of the 
leaf.[91] 
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Procedure  
 A leaf of 5x5mm2 was taken in a test tube containing chloral hydrate solution and 
heated on a water bath for about 15min, until the fragments are transparent. The upper and 
lower epidermis was peeled out separately by using a forceps. The transparent leaf was 
placed on the slide and mounted with few drops of glycerine,cover slip was placed on the top. 
With the help of camera lucida and stage micrometer 1mm square was drawn on the black 
chart. The epidermis and the stomata were traced. The number of stomata present in the area 
of 1mm square including the cell if at least half of its area lies within the square was counted. 
The results for each field were calculated and the average number of stomata per square mm 
was measured and their values are tabulated in Table 2. 
Stomatal Index [89, 90] 
Stomatal index is the percentage which the number of stomata to the total number of 
epidermal cells, each stoma being counted as one cell.Stomatal index was calculated by using 
the following formula - S.I = S/(E+S) x 100; where S.I is thestomatal index, S is the number 
of stomata in 1sq mm of the leaf and  E is the number of epidermal cells in the same unit 
area. 
Procedure 
 For stomatal index, the glycerine mounted leaf peeling was taken and circle (O) like 
mark for each stomata and cross (X) like mark for each epidermal cell was marked on the 
chart paper. From these values, stomatal index was calculated from the formula and the 
values are tabulated in Table 2. 
Determination of vein islets and vein terminations[87,89] 
Vein Islets 
 Vein islet is used to indicate the minute area of the photosynthetic tissues encircled by 
the ultimate divisions of the vascular strands. The area of the leaf that is preferably taken is 
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from the lamina midway between the midrib and margin.The number of vein islet/sq. mm. is 
termed as vein islet number. This number per unit area of leaf is constant. 
Vein Terminations 
 An ultimate free end or termination of a vein islet is called vein termination. The 
number of vein terminals/ sq. mm. of the leaf surface is termed as vein termination number. 
Procedure [90] 
 A piece of fresh leaf was cut from the middle portion of the lamina avoiding midrib 
and the margin and taken in a test tube and boiled with chloral hydrate solution in a water 
bath, until they are cleared enough for observation. The cleared fragments were stained with 
saffarin solution and a temporary mount was prepared with glycerol solution. The stage 
micrometer was placed and examined under 10 x objective and an area of 1sq. mm. was 
drawn. The cleared leaf piece was placed on the microscope stage, the vein islets and 
terminals within the square were counted. The results obtained for each number of vein islets 
and terminals in 1 sq.mm.are tabulated in Table 2. 
SECTION E - POWDER ANALYSIS AND POWDER MICROSCOPY 
Powder Microscopy 
 The dried leaf material was powdered and the powder was passed through sieve no. 
60 for the study of powder microscopy. Chloral hydrate, glycerine, iodine, phloroglucinol, 
hydrochloric acid (1:1), lacto phenol etc. were employed as mounting medium. The pictorial 
representation was presented in Fig.11.  
Powder analysis 
The reaction of the powder sample with different chemical reagents was carried out as 
per Kay (1938) and Johanson (1940). The results are presented in Table 3. 
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Fluorescence analysis  
 The fluorescence analysis of the drug powder as well as the plant extracts 
ofCostuspictus D. Don were carried out by using the method of Chase and Pratt (1949). The 
results are presented in Table 4. 
SECTION F - STANDARDIZATION PARAMETERS 
 The evaluation of ash values, loss on drying, foreign organic matter and extractive 
values etc., gives a clear idea about the specific characteristics of crude drug under 
examination, besides its macro-morphology or cyto-morphological, microscopical nature in 
both its entire and powder form. These diagnostic features enable the analyst to know the 
nature and characteristic of crude drugs. The procedures recommended in Indian 
Pharmacopoeia 1996, WHO guidelines 1998 and The Ayurvedic Pharmacopoeia of India 
were followed to calculate the total ash, water-soluble ash, acid-insoluble ash and loss on 
drying. The percentage of extractive values for different solvents was also determined.[85,86] 
Determination of Volatile Oil 
 Volatile oils are the odorous principals found in various plant parts. Because they 
evaporate when exposed to air at ordinary temperatures, they are called volatile oils, ethereal 
oils or essential oils. Volatile oils are mainly composed of mono and sesquiterpenes and 
phenolic compounds.[87] 
 Volatile oils are extracted by 
i) Steam distillation  
ii) Solvent extraction 
iii) Mechanical means such as eculle and enfluerage technique [88] 
Procedure 
 The essential oil was isolated fromCostuspictusby hydro distillation method. An 
accurately weighed 100g of the fresh leaves was crushed and introduced in to the round 
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bottom flask with a mixture of water and glycerine. The graduated receiver was filled with 
the water to avoid air bubbles. A few porcelain pieces were added. Then the distillation was 
allowed to continue for 3h. After 3h, heating was stopped and the oil obtained was collected 
in the volatile oil container. The percentage yield of the oil was calculated using the 
following formula - [Volatile oil obtained/ wt. of the sample taken] x 100. The oil content of 
the plant material was calculated in mL/100g of plant material and the result was reported in 
the Table 5.  
Determination of Moisture Content (Loss on drying) 
 Loss on ignition is the loss in weight in percentage w/w resulting from a part of any 
test material that is volatilized and driven off under specified conditions. The test is 
performed on finely powdered material; lumps, if any should be broken up with the aid of a 
mortar and pestle.[85] 
Procedure 
 An accurately weighed 10g, of the drug sample in a petridishwhich was previously 
dried under the conditions specified in IP’96. The powder was distributed evenly by gentle 
sidewise shaking.  Then the petridish was dried at 105oC for 5h and weighed. After 5h, the 
petridish was cooled in the desiccator to room temperature. The drying and weighing was 
continued at one hour interval until difference between two successive weighing corresponds 
to not more than 0.25%. The L.O.D was calculated with reference to the amount of air dried 
powder. The results obtained are presented in Table 5. 
Determination of Ash value[85,86] 
Ash content 
The residue remaining after incineration is the ash content of crude drugis the residue 
of the extraneous matter (eg. sand and soil) that adhere to the plant surface.Ash content is 
determined by three different methods; which measures 
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a) Total ash 
b) Acid insoluble ash 
c) Water soluble ash 
Determination of Total ash 
  An accurately weighed 2g, of the powdered drug was taken in a tared crucibleand 
incinerated by gradually increasing the heat to 500-600oC until it was free from carbon. Then, 
it was cooled and weighed for constant weight. The percentage yield of ash with reference to 
the air dried drug was calculated.The results obtained are presented in Table 5. 
Determination of Acid- insoluble ash 
 Acid insoluble ash is the residue obtained after boiled the total ash with dilute 
hydrochloric acid, and igniting the remaining insoluble matter. This measures the amount of 
silica present, especially as sand and siliceous earth.   
Method 
 To the total ash obtained 25mL of 2M hydrochloric acid was added and boiled for 
5min. Then, the insoluble matter was collected in an ashless filter paper and washed with hot 
water until the filtrate became neutral and ignited for 15min at a temperature not exceeding 
450oC and cooled in a desiccator and weighed. The percentage yield of acid-insoluble ash 
with reference to the air dried drug was calculated. The results obtained are presented in 
Table 5. 
Determination of Water soluble ash 
 Water soluble ash is the difference in weight between the total ash and the residue 
after treatment of the total ash with water. 
Method  
 The total ash obtained was mixed with 25mL of water and boiled for 5min in a water 
bath. The insoluble matter was collected in the ashless filter paper and washed with hot water  
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and ignited in a crucible for 15min at a temperature not exceeding 450oC and cooled in a 
desiccator and weighed. The weight of this residue in mg was subtracted from from the 
weight of total ash. The percentage of water soluble solution ash with reference to the air 
dried drug was calculated.  The results obtained are presented in Table 5. 
Determination of Foreign Organic Matter [86] 
 Any organ or part of organ other than those specified in the definition and description 
is termed as foreign organic matter. 
Procedure 
 An accurately weighed 100g of the plant material and spread it out in a thin layer. The 
plant material was detected by inspection with unaided eye or by the use of a lens (6x). Then, 
the foreign matter was separated and weighed. The percentage yield of the foreign organic 
matter was calculated with reference to the drug taken. The results obtained are presented in 
Table 5. 
Determination of Extractive Values 
 Extractive values are used to determine the amount of active constituents in a given 
amount of medicinal plant material, when extracted with suitable solvent. The extraction of 
crude drug with a particular solvent yields a solution containing different phytoconstituents. 
The composition of these phytoconstituents in that particular solvent depends upon the nature 
of drug and solvent used. The use of single solvent can be means of providing preliminary 
informationon the quality of the particular drug sample.[85,86] 
Determination of ethanol soluble extractive value[86,87] 
 An accurately weighed 5g of the air dried coarsely powdered drug was macerated 
with 100mL of ethanol in a conical flask for 24h,shaking frequently during the first 6h and 
allowed to stand for 18h. Thereafter, filter rapidly taking precautions against loss of ethanol. 
25mL, of the filtrate was evaporated to dryness in a china dish and dried at 105oC and 
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weighed. The percentage of ethanol soluble extract with reference to the air dried drug was 
calculated. The results obtained are presented in Table 5. 
Determination ofmethanol soluble extractive value 
 An accurately weighed 5g of the air dried coarsely powdered drug was macerated 
with 100mL of methanol in a conical flask for 24h,shaking frequently during the first 6h and 
allowed to stand for 18h. Thereafter, filter rapidly taking precautions against loss of 
methanol. 25mL, of the filtrate was evaporated to dryness in a china dish and dried at 105oC 
and weighed. The percentage of methanol soluble extract with reference to the air dried drug 
was calculated. The results obtained are presented in Table 5. 
Determination of Chloroform soluble Extractive Value 
 An accurately weighed 5g of the air dried coarsely powdered drug was macerated 
with 100mL of chloroform in a conical flask for 24h,shaking frequently during the first 6h 
and allowed to stand for 18h. Thereafter, filter rapidly taking precautions against loss of 
chloroform. 25mL, of the filtrate was evaporated to dryness in a china dish and dried at 
105oC and weighed. The percentage of chloroform soluble extract with reference to the air 
dried drug was calculated. The results obtained are presented in Table 5. 
Determination of water soluble extractive value 
 The procedure adopted under ethanol soluble extractive was followed using water as a 
solvent. The results obtained are presented in Table 5. 
Determination of petroleum ether soluble extractive value 
The procedure adopted under ethanol soluble extractive was followed using petroleum 
ether as a solvent. The results obtained are presented in Table 5. 
Determination of benzene soluble extractive value 
The procedure adopted under ethanol soluble extractive was followed using benzene 
as a solvent. The results obtained are presented in Table 5. 
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Determination of ethyl acetate soluble extractive value 
The procedure adopted under ethanol soluble extractive was followed using benzene 
as a solvent. The results obtained are presented in Table 5. 
Determination of Foaming Index[86,87] 
 Many medicinal plant materials contain saponins that can cause persistent foam when 
an aqueous decoction is shaken. The saponins are high molecular weight containing 
phytoconstituents having detergent activity. The foaming ability of an aqueous decoction of 
plant materials and their extracts is measured in terms of foaming index.The WHO has 
recommended the following procedure for the determination of the foaming index. 
Method  
 An accurately weighed 1g of a coarsely powdered drug sample was taken in 500mL 
of conical flask containing 100mL of boiling water. Then, the conical flask was maintained at 
moderate boiling for 30min. Then, the flask was cooled and filtered in to a 100ml volumetric 
flask and sufficient amount of distilled water was added to dilute to volume. The decoction 
obtained was poured in to 10 stoppered test tubes in successive portion of 1mL, 2mL, 3mL, 
etc., up to 10mL and the volume in each test tube was adjusted to 10mL with water. Then, the 
test tubes were stoppered and shaken them in a length wise motion for 15sec(two shakes/sec) 
and allowed to stand for 15min and the height of  the foam was measured.The results are 
assessed as follows;  
 If the height of the foam in every test tube was less than 1cm, the foaming index was 
less than 100. 
 If the height of the foam of 1cm was measured in any test tube, the volume of the 
plant material decoction in this tube (a) was used to determine the index.If the height of the 
foam was more than 1cm in every tube, the foaming index was over 1000. In this case repeat 
the determination using a new series of dilutions of the decoction in order to obtain a result.  
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The foaming index was calculated using the formula - 1000/a; where a = the volume in ml of 
the decoction used for preparing the dilution in the tube where foaming to a height of 1cm 
was observed. The result obtained is presented in Table 5. 
Determination of Swelling Index[86] 
 Swelling index is the volume in mL taken up by the swelling of plant material under 
specified conditions. The medicinal plant materials like gums, mucilage, and pectin have 
swelling property. 
Method  
 An accurately weighed 1g of the powdered drug material was taken in the 25mL glass 
stoppered measuring cylinder. 25mL of water was added and shaken the mixture thoroughly 
every 10min for 1h. Then, allowed to stand for 3h at room temperature. The volume in mL 
occupied by the plant material was measured, including sticky mucilage was observed.The 
result obtained is presented in Table 5. 
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RESULTS AND DISCUSSION 
SECTION A - MACROSCOPICAL OBSERVATION 
CostuspictusD. Don is a perennial herb. The plant is a hardy vigorous growing ginger. 
The stem is red with spiral light leaves and airy, the tissue paper like flowers. (Fig. 5.1) 
Leaf 
The leaves are simple, large fresh looking spirally arranged, oblong-lonceolate being 
dark green above and lighter green below. Acumin has filiform point 2-3mm. The shape of 
the leaf is narrowly elliptic with the length 10 to 25cm and width 2.5 to 6cm. (Fig. 5.3) 
Flower 
The flowers are in terminal cone, (Fig. 5.4)yellow in colour with an orange red tip and 
lasts for 3-4 days and spread 1.5-2m. The flowers do not produce an aroma. It flowers 
throughout spring and summer. (Fig. 5.5) 
Bract:  The length and width of the bract is 2-4cm and 2-4cm respectively. The bract is green 
with maroon outer margin.  
Bracteolate : The length of the bracteolate is 1.6-2.1cm. 
Calyx : The calyx is 4-10mm long with lobes 2-3.5 mm long.  The length of calyx 
is 6.5 cm. 
Corolla : The corolla is yellow to red in colour and 65mm long. 
Labellum : The lobes are yellow to red striped and irregularly trilobulate and the mid 
lobule is tridenate. The shape is obovate spread, margin crenulate. 
Stamen : The anther is cream or yellow and 7-8mm long. The apex is dark red and 
4 to 4.5cm long and 0.9 to 1.5cm wide. 
Stem  
 Fig.5.1: Diagram showing Macroscopy of Costus pictus D. Don 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.2: HABITAT OF Costus pictus D. Don 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.3: WHOLE PLANT OF Costuspictus D. Don 
 
 
 
 
 
 
 
 
 
 
Fig. 5.4: CONE OF Costuspictus D. Don  Fig. 5.5: FLOWERS OF Costus pictus D. Don 
 
 
 
 
 
 
 
 
 
 
Fig.5.6. LEAF DORSAL AND VENTRAL VIEW OF Costus pictus D. Don 
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The red painted stem enhances the beauty of glossy linear leaves and strongly spirally 
canes. (Fig. 5.3) 
Fruits 
The fruits are globose capsules containing obovoid seeds. 
SECTION B – SENSORY EVALUATION 
Nature  -  Coarse Powder 
Colour   - Pale Green   
Odour              - Aromatic odour 
Taste                -  Sour 
SECTION C – MICROSCOPICAL EVALUATION 
T.S. of Leaf through adaxially depressed Midrib 
Leaf is shallowly boat shaped, having a group of vascular bundles. This part of the 
leaf represents the midrib. (Fig.6.1)The midrib is 750µm thick. It consists of thin epidermal 
layer of small squarish cells on the adaxial side and fairly thick cylindrical epidermal cells on 
the adaxial side (Fig. 6.1). The ground tissue includes, wide, thin walled compact 
parenchyma cells with shrunken walls.(Fig. 6.2) 
 The vascular system of the midrib includes an abaxial band of three vascular bundles 
and adaxial single median bundle. The adaxial vascular bundles have only a few xylem 
elements; these are two or three wide circular xylem elements, but the phloem is a large mass 
of sieve elements.(Fig. 6.2) 
 Fig.6.1: T.S. of leaf through adaxially depressed midrib 
 
 
 
 
 
 
 
 
Fig. 6.2: Midrib vascular bundle enlarged 
 
Fig. 6.3: The adaxial median bundle enlarged 
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 The abaxial solitary bundle has a single, wide, circular thin walled xylem elements 
and a small clusters of phloem elements located on the upper side (Fig.6.3). The vascular 
bundle is surrounded by wide layer of parenchymatous bundle sheath. 
 The vascular bundles of the lamina occur in a single horizontal row of the median part 
of the lamina. The lamina- bundles also have one or two wide circular xylem elements and 
thick clusters of phloem and parenchymatous bundles heath (Fig.7.1 & 7.2). The adaxial 
epidermal layers of the lamina consist of thick, cylindrical cells. 
The abaxial epidermis is thin and it consists of narrow tubular cells. The adaxial 
epidermis is apostomatic. The adaxial epidermis is stomatiferous. (Fig.7.1) 
Crystal distribution (Fig.8.1 & 8.2) 
Calcium oxalate crystals of minute particle are aggregated in to large masses in the 
leaf mesophyll cells. These microcrystal masses are random and diffuse in distribution. The 
crystals are located in ordinary unspecialized cells. 
Epidermal cells and stomatal morphology (Fig.9.1 & 9.2) 
The epidermal cells and stomata were observed in the paradermalsectious(Fig.9.1 & 
9.2). The epidermal cells are rectangular or polygonal; the anticlinal wallsare thick and 
straight. The stomata are diffuse in distribution. They are surrounded by the two pairs of 
lateral subsidiary cells. This type of stomata is called hexacytic type. The guard cells are 15 X 
30µm in size. 
Venation pattern (Fig.10.1 & 10.2) 
 The leaf exhibits fairly prominent parallel main veins. The main parallel veins are 
interconnected by thin, less prominent horizontal veins. 
 Fig.7.1: T.S. of lamina with laminar vascular bundle 
 
 
Fig.7.2: Lateral laminar vascular enlarged 
 
 
 Fig. 8.1: Crystal distribution in the leaf mesophyll 
 
Fig. 8.2: One crystal enlarged 
 
 Fig.9.1: Paradermal section showing stomata on the abaxial epidermis 
 
Fig. 9.2: One stoma enlarged 
 
 
 
Fig. 10.1: Venation pattern of the lamina 
 
 
Fig. 10.2: Venation pattern of the lamina enlarged 
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SECTION D - QUANTITIATIVE ANALYTICAL MICROSCOPY 
 The results obtained for the determination of leaf constants are presented in Table 2. 
From the table, it can be observed that the number of stomata in the upper epidermis was 
found to be 2.17±0.05 while in the lower epidermis it was 13.0±0.28.The stomatal index in 
the upper epidermis and lower epidermis was 3.5±0.28 and 10.38±0.23 respectively. The vein 
islet number was found to be 4.1±0.057 and the vein termination number was 3.9±0.088. 
These values help in identification of leaf of Costuspictus D. Don from other species of the 
genus Costus.  Since these values are unique for each plant. 
Table 2: Quantitative analytical microscopical 
parameters of the leaf of  CostuspictusD.Don 
 
S. No. Parameters* Values obtained 
1 Stomatal number  in upper epidermis 2.17±0.05 
2. Stomatal number  in lower epidermis 13.0±0.28 
3. Stomatal index in upper epidermis 3.5±0.28 
4. Stomatal index in lower epidermis 10.38±0.23 
5. Vein islet number 4.1±0.057 
6 Vein termination number 3.9±0.088 
* mean of 6 readings ± SEM 
 
 
SECTION E - POWDER MICROSCOPY AND POWDER ANALYSIS 
Powder microscopic characters 
 The leaf powder ofCostuspictusD. Don was studied under the microscope and the 
following inclusions were observed (Fig. 11). The microscopic analysis of the powder of the 
leaf showed fragments of simple unicellulartrichomes, hexacyticstomata,abaxial solitary 
bundle has a single, wide, circular thin walled xylem elements and a small clusters of phloem 
elements located on the upper side.The vascular bundle is surrounded by wide layer of 
parenchymatous bundle sheath, mesophyll cells containing starch grains, Calcium oxalate 
 
 
Fig. 11 Powder Microscopy of Costus pictus D. Don 
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crystals of minute particle are aggregated in to large masses in the leaf mesophyll cells, 
Tracheids with spiral thickenings and epidermal cells, fibres are observed. 
Behaviour of powder with different reagents 
The behavior of crude leaf powder of Costuspictus D. Don with various reagents is 
presented in Table 3. From the table, it can be observed that the powder with 10% potassium 
hydroxide under UV light at 254nm exhibited a greenish florescence which will be useful for 
identification of the plant material in crude form.  
Table 3: Behaviour of the CostuspictusD. Don powder with various chemical reagents 
 
Drug powder + reagent 
Colour in 
day light 
(Visible) 
Colour in UV light 
254nm 365nm 
Powder Pale green Green Pale green
Powder + 1M sodium hydroxide Brownish green Green Brown 
Powder + Iodine Green Dark green Brown 
Powder + 10% potassium hydroxide Light brown Fluorescent green Brown 
Powder + 1M Hydrochloric acid Pale green Dark green Green 
Powder + Glacial acetic acid Dark green Dark green Green 
Powder + 50% sulphuric acid Dark green Dark green Green 
Powder + 50% nitric acid Brick red Green Green 
Powder + 50% hydrochloric acid Pale green Dark green Green 
 Note: Colour reactions are viewed under natural light by naked eye 
Fluorescent analysis of the Extracts 
 The behaviour of various extracts of Costuspictus D. Don in natural light and under 
UV light at 254nm and 365nm are presented in Table 4. From the table, it was observed that 
the benzene was orange and ethyl acetate extracts were red under UV light at 254nm. These 
parameters are useful for quality control and purity checking of the plant in powder form. 
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Table 4:  Fluorescence Analysis of extracts of CostuspictusD. Don 
Extract Consistency 
Colour in day 
light 
Colour in UV light 
254nm 365nm 
Ethanol Semisolid Yellowish  green Brown Yellowish green 
Methanol Semisolid Dark green Brown Yellow colour 
Chloroform Semisolid Dark green Brown Brown 
Ethyl acetate Semisolid Dark green Red Green 
Water Semisolid Dark green Green Brown 
Benzene Semisolid Green Orange Brownish green 
Petroleum ether Semisolid Green Brown Brown 
 
STANDARDIZATION PARAMETERS 
 The results obtained for various standardization parameters are presented in Table 5. 
Table 5: Standardization parameters of CostuspictusD. Don 
S. No Parameters* Values*expressed as % 
1 Volatile oil   0.96 ± 0.033 
2 Moisture content 12.38 ± 0.008 
3 Ash values   
 Total ash  15.28 ± 0.140  
 Acid insoluble ash   3.17 ± 0.080 
 Water soluble ash    9.70 ± 0.110 
4 Foreign organic matter   0.06 ± 0.080 
5 Extractive Values  
 Petroleum ether 25.74 ± 0.150 
 Chloroform    7.20 ± 0.300 
 Ethyl acetate   8.60 ± 0.030 
 Ethanol   5.10 ± 0.110 
 Methanol  16.25 ± 0.040 
 Water 11.12 ± 0.600 
 Benzene   5.76 ± 0.090 
6 Foaming index Less than100 
7 Swelling index expressed as mL 
  Initial volume     3.2± 0.10 
 Final volume    7.6 ± 0.140 
* mean of three readings ± SEM 
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 From the Table 5, it can be seen that the foreign organic matter present in the crude 
material was very low. The percentage of total ash was found to be 15.28 ±0.14 and the 
percentage of water soluble ash was found to be 9.7 ± 0.11, while the acid insoluble ash was 
found to be 3.17 ± 0.08.  
The determination of ash values helps to find out where the powdered material was 
adulterated with sand and other inorganic material. The water soluble ash helps us to find the 
amount of inorganic material present in the crude drug while acid insoluble ash helps us to 
find the amount of sand and other debris in the crude material.  
 The various extractive values with different solvents have been determined. A 
maximum extractive value was found with petroleum ether 25.74 ± 0.15 followed by 
methanol 16.25 ± 0.04. The extractive values help us to decide what solvent will be useful for 
extraction of maximum active principles and also helps to decide whether the crude material 
has already been exhausted or not. 
The pharmacognostical studies of Costuspictus D. Don gave the valuable information 
regarding the morphology of crude drugs. They can be useful for the authentication of this 
plant among all species of Costus. The microscopic character, leaf constants, quantitative 
analysis and physico-chemical parameters studied are useful for setting standards for crude 
drug and to judge the adulteration and purity of this drug. Since the parameters are constant 
and any change in these values are indicative of substitution and adulteration of the plant 
materials. 
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CHAPTER – 6 
SYNTHESIS OF METHANOLIC LEAF EXTRACT OF 
CostuspictusD.Don SILVER NANOPARTICLES [91-101] 
 
Nanoparticles are materials with overall dimensions in the nanoscale. In recent years, 
these materials have emerged as important players in modern medicine, with applications 
ranging from contrast agents in medical imaging to carriers for gene delivery into individual 
cells. Nanoparticles have a number of properties that distinguish them from bulk materials 
simply by virtue of their size, such as chemical reactivity, energy absorption, and biological 
mobility. 
Nanoparticles can be broadly classified into two groups: Organic nanoparticles and 
Inorganic nanoparticles. Organic nanoparticle are carbon nanoparticle (fullerenes) and 
inorganic nanoparticles are magnetic nanoparticles, noble nanoparticles (gold and silver), 
semiconductor nanoparticles (titanium oxide and zinc oxide). 
 Metallic nanoparticlesare emerging as new carriers and have been used for a huge 
number of applications in various areas of medical treatment. Recent advances have opened 
the way to site-specific targeting and drug delivery by these nanoparticles. 
Silver (Ag) a noble metal, has potential applications in medicine due to its unique 
properties.[91]Silver nanoparticles have attracted research in the field of nanotechnology, due 
to its distinct properties such as good conductivity, chemically stable, catalytic activity, 
surface enhanced Raman scattering and antimicrobial activity.[92,93] There are various 
methods for silver nanoparticles preparation, for example; sol-gel process, chemical 
precipitation, reverse micelle method, hydrothermal method, microwave, chemical vapor 
depositionand biological methods, etc.[9] However; biologicalmethods are preferred for being 
eco-friendly, cost effective, and don’t involve the use of toxic chemicals. 
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The possibility of using plant materials for the synthesis of nanoscale metals was 
reported initially byGardea-Torresdey. The biosynthesis of nanoparticles, which represents a 
connection between biotechnology and nanotechnology, has received increasing 
consideration due to the growing need to developenvironmental friendly technologies for 
material syntheses. The search for appropriate biomaterials for the biosynthesis of 
nanoparticles continues through many different synthetic methods. 
 Plants can be described as nano factories which provide potential pathway to 
bioaccumulation into food chain and environment. Among the different biological agents 
plants provide safe and beneficial way to the synthesis of metallic nanoparticle as it is easily 
available so there is possibilities for large scale production apart from this the synthesis route 
is eco-friendly, the rate of production is faster in comparison to other biological models such 
as bacteria, algae and fungi. 
 In this study, the synthesis and characterization of Ag/CostuspictusD. Donby a green 
method is reported. The Ag-NPs were prepared using silver nitrate as silver precursor and 
Costuspictus leafmethanolic extract as reducing agent and stabilizer. 
MATERIALS AND METHODS 
All the glasswares were washed with dilute nitric oxide followed by double distilled 
water and dried in hot air oven. 
 Chemical reagents  
Methanol  
Silver nitrate (AgNO3) 
Double distilled water 
 Instruments Required 
  Centrifuge (REMI) 
  Magnetic stirrer with hot plate 
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  Lyophilizer (Lyodel-Delvac Pumps Pvt. Ltd, USA) 
  Shimadzu UV-Visible spectrophotometer, Model 1800 
Scanning Electron Microscopy (Hitachi X650, Tokyo, Japan) 
Procedure 
Collection of the leaves   
Healthy plant leaves of CostuspictusD.Don were collected and cleaned properly in 
running tap water. 
Leaf drying and pulverizing 
The leaves were collected and shade dried. It was powdered in a mixer. The powder 
was sieved in a No.60 sieve and kept in a well closed container in a dry place. 
Preparation of methanolic leaf extracts of Costuspictus D. Don 
About 500g of the dried powdered leaf of CostuspictusD. Donwas defatted with 1.5L 
petroleum ether (60-800 C) by maceration.  The solvent was removed by filtration and the 
marc was dried. To the dried marc 1.5L of methanol was added and the extraction was 
performed by triple maceration (72h process).  It was then filtered and the combined filtrate 
was evaporated to a cohesive mass using rota vapour. 
Preparation of stock solution 2mg/20mL 
2mg of the methanolic extract was weighed and diluted to 20mL with methanol. It 
was stored at 4◦C until further use.[99] (Fig.12). 
Preparation of 1mM silver nitrate aqueous solution (AgNO3): 
An accurately weighed 0.017g of silver nitrate was dissolved with 100mL of double 
distilled water and stored in amber colour bottle until further use (Fig.13). 
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Synthesis ofmethanolic leaf extracts of Costuspictus D. Don silver nanoparticles 
(MECPAgNPs) 
5mL of the methanolic leaf extract of CostuspictusD. Don was taken in the conical 
flask separately and placed on a magnetic stirrer with hot plate. To this 50mL of 1mM 
AgNO3 solution was added dropwise with constant stirring 120rpm at 50-60◦C. The colour 
change of the solution was checked periodically. The colour change of the medium from 
colourless to brown after 5h (Figs.14.1 to 14.6)was observed which indicated the formation 
of silvernanoparticles. It showed that aqueous silver ions could be reduced by the methanolic 
extract of CostuspictusD. Donto generate extremely stable silver nanoparticles.[99] 
Seperation of silver nanoparticles 
The synthesized silver nanoparticles were separated by centrifuging using a centrifuge 
at 10,000rpm for 15min. The supernatant liquid was re-suspended in the sterile double 
distilled water. The process was carried out thrice to get rid of any unco-ordinated 
biomolecules. After, the desired reaction period, the supernatant liquid was discarded and the 
pellets were collected and stored at 4◦C for further use.[100] 
Lyophilization 
The pellet obtained was then lyophilized by using freeze dryer (Lyodel-Delvac Pumps 
Pvt. Ltd, USA) to enhance the stability of silver nanoparticles. The freshly prepared 
MECPAgNPs are lyophilized with cryoprotective agent (mannitol). Then it was rapidly 
cooled down to -500C for 2h followed by primary drying at 1.03mbar and secondary drying at 
0.001mbar.[100] After lyophilization the synthesizedMECPAgNPs was stored at 4◦C for 
further use (Fig. 15). 
Characterization of synthesized MECPAgNPs 
The characterization of synthesized MECPAgNPswas carried out by using the 
following analytical parameters 
 
Figs. showing the colour change of the medium from  
colourless to brown colour after 5hrs 
 
  Fig. 14.1 At 0 mins Fig. 14.2 After 1hr  Fig. 14.3 After 2hrs 
 
 
 
 
 
 
Fig. 14.4 After 3hrs   Fig. 14.5After 4hrs          Fig. 14.6 After 5hrs 
 
 
 
 
 
 
 
Fig. 15: Synthesized MECPAgNPs 
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Particle size 
Zeta potential studies 
Polydispersity index 
UV-Visible spectal analysis 
Morphological studies using SEM 
Determination of Particle size and Zeta potential 
The mean particle size (z-average), polydispersity index (PI) and zeta potential of 
MECPAgNPswere determined by dynamic light scattering technique using a zeta size 
analyzer (Nano ZS 90, Malvern Instruments Ltd.,UK). The freeze dried powders were 
dispersed with water to obtain a proper scattering intensity before measurement.[100] The 
results obtained are presented in the Table.6 & Figs.16, 17. 
UV-Visible spectroscopy 
The formation and completion of silver nanoparticles was characterized by UV-
Visible spectroscopy by using Shimadzu UV- Visible spectrophotometer, Model 1800. The 
bio-reduction of the Ag+ ions in solution was monitored by periodical sampling of aliquots 
and the UV-Visible spectra of these aliquots were monitored as a function of time of reaction 
in 200-600nm range operated at a resolution of 1nm. Distilled water was used as a blank.[62] 
The results obtained are presented in the Fig. 18. 
Morphological studies of synthesized MECPAgNPsby using Scanning Electron 
Microscopy (SEM) 
 
Morphological evaluation of theMECPAgNPs was carried out by using scanning 
electron microscope(SEM) (Hitachi X650, Tokyo, Japan). SEM gave high-resolution images 
on the surface of the sample. The scanning electron microscope workedon the same principle 
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of an optical microscope, but it measured the electrons scattered from the sample rather than 
photon 18.Because electrons can be accelerated by an electric potential, the wavelength can 
be made shorter than the one of photons. This made the SEM capable of magnifying images 
up to 200.000 times. At the same time it was possible to achieve high resolution pictures of 
the surface, making the instrument very useful in determining the morphology and size of 
nanoparticles. Thin films of a sample prepared on a carbon grid by just dropping a very small 
amount of the sample on the grid, extra solution was removed by using a blotting paper and 
then the film on the SEM grid was allowed to dry by keeping it under the mercury lamp for 5 
minutes. Further the secondary electron sputtering at an applied potential of20 kV was 
adopted prior to recording the SEM.[99] The results are depicted in theFig. 19. 
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RESULTS AND DISCUSSION[102-105] 
Synthesis ofMethanolic Leaf extracts of Costuspictus D. Don silver nanoparticles 
(MECPAgNPs) 
 
There was a visible color change after the substrate was added to the plant extract. 
Initially the plant extract was colourless. Upon adding the silver salt, it turned brown. After 5h, 
no significant colour change was observed. Increased concentrations of silver nitrate resulted 
in a brown solution of nanosilver indicating the completion of reaction. Reduction of silver 
ions into silver nanoparticles using methanolic leaf extract of CostuspictusD. Don was 
evidenced by visual change of colour from colourless to brown colour which indicated the 
formation of silver nanoparticles due to the excitation of surface Plasmon vibration in silver 
nanoparticles[102]as shown in Figs. 14.1 to 14.6. 
Determination of Particle size and Zeta potential 
Particle size, size distribution and zeta potential were important characterizations of 
the silver nanoparticles because they govern the other characterizations, such as saturation 
solubility and dissolution velocity, physical stability, or even biological performances.[103] 
Particle size measurements: Mean particle size diameter and polydispersity indices were all 
measured in solutions directly after synthesis, using photon correlation spectroscopy (PCS). 
The size of the colloidal silver nanoparticles, their granulometric distribution has been 
recorded, expressed against the particles number and their occupied volume.[70] 
 The average particle size (z-average) is found to be 132.6 nm. Particle size analysis 
showed the presence of nanoparticles with polydispersity indices PDI value0.248 with 
intercept 0.643. It is presented in the Table 6 & Fig. 16. 
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Table 6: Mean Particle Size Diameter and Polydispersed Index (PDI) of Bio-
synthesized MECPAgNPs 
 
Parameter Value Peak No 
Peak 
Size 
(d.nm) 
Peak 
Intensity 
% 
Peak 
Width 
(d.nm) 
Z-Average (d.nm) 132.6 Peak 1 141.8 100.0 102.5 
PDI 0.248 Peak 2 0.000 0.000 0.000 
Intercept 0.643 Peak 3 0.000 0.000 0.000 
 
 
 
 
Fig. 16: Percentageintensity of particle size distribution 
of bio-synthesized MECPAgNPs 
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Fig. 17: Zeta potential distribution of bio-synthesized MECPAgNPs 
 
 
Zeta Potential measurement: a zeta potential was used to determine the surface 
potential of the silver nanoparticles. Zeta potential is an essential characterization of stability 
in aqueous silver nanoparticles. A minimum of +30mV zeta potential is required for the 
indication of stable silver nanoparticles. For the obtained nanoparticles, zeta values were 
measured and found to be -25.1mV with apeak area of 100% intensity. These values provide 
full stabilization of the nanoparticles, which may be the main reason in producing particle 
sizes with anarrow size distribution index.(Fig. 17) 
UV-Visible Spectroscopy: The UV-Vis Spectroscopy was the preliminary technique 
for the characterization of the silver nanoparticles. The reduction of the pure Ag+ ions was 
monitored by measuring the UV-Vis spectrum of the reaction medium at 5 hours (complete 
colour change) following the dilution of a small aliquot of the sample in distilled water. The 
UV-Vis spectral analysis was conducted usingShimadzu UV-Vis spectrophotometer, Model 
1800 range between 200 and 600 nm.The reduction of silver ions in the aqueous solution of 
nanoparticles in the solution could be correlated with the respective UV-Vis Spectra of the 
colloidal solution which exhibited a strong absorption at 420nmas shown in Fig. 18.A typical 
peak was obtained due to the presence of surface Plasmon resonance silver nanoparticles.[104] 
Surface Plasmon resonance: Surface plasmon resonance (SPR) is the collective 
oscillation of electrons in a solid or liquid stimulated by incident light. 
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The resonance condition is established when the frequency of light photons matches the 
natural frequency of surface electrons oscillating against the restoring force of positive 
nuclei. SPR in nanometer-sized structures is calledlocalized surface plasmon resonance.[105] 
SPR is the basis of standard tools for measuring adsorption of material onto planar metal 
(typically gold and silver) surfaces or onto the surface of metal nanoparticles. It is the 
fundamental principle behind many color-based biosensorapplications and different lab-on-a-
chipsensors. 
Fig. 18: UV-Vis spectra of MECPAgNPs 
 
MECPAgNPs 
      1mM AgNo3 
       MECP 
 
 
 
Morphological studies of silver nanoparticles by using Scanning Electron Microscopy 
(SEM) 
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Morphological studies of silver nanoparticles by using Scanning Electron Microscopy 
(SEM) 
A SEM employed to analyze the morphology and size details of the silver 
nanoparticles that were formed. From (Fig. 19) it was showed that the silver nanoparticles 
formed were spherical in shape, with an average size of around 100nm and uniformly 
distributed silver nanoparticles on the surface of the cells was observed.  
 
Fig.19: SEM images of MECPAgNPs 
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CHAPTER 7 
PHYTOCHEMICAL EVALUATION [106-129] 
 
Phytochemistry is the branch of chemistry concerned with plants. It deals mainly with 
the variety of secondary metabolites that are produced by the plants, their chemical 
structures, biosynthesis, metabolism, natural distribution and biological functions. 
Phytochemical evaluation of plant is essential to study the pharmacological activities. It can 
be done by qualitative chemical analysis using specific reagents for specific constituents 
followed by confirmation with different chromatographic techniques, like TLC, HPTLC, 
HPLC, GC etc. Therefore a complete investigation is required to characterize the 
phytoconstituents qualitatively and quantitatively, before proceeding for its pharmacological 
and toxicological studies. 
MATERIALS AND METHODS 
COLLECTION AND PREPARATION OF EXTRACT  
The leaves of Costus pictus D. Don were collected and washed thoroughly and dried 
in shade. The shade dried leaves were powdered and sieved in a No.60 sieve and used for the 
further studies 
 About 500gof the dried powdered leaf of Costus pictus D. Don was defatted with 
1.5L petroleum ether (60-800 C) by maceration.  The solvent was removed by filtration and 
the marc was dried. To the dried marc 1.5L of methanol was added and the extraction was 
performed by triple maceration (72h process).  It was then filtered and the combined filtrate 
was evaporated to a cohesive mass using rota vapour. 
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SECTION A - QUALITATIVE CHEMICAL TESTS FOR THE LEAF POWDER AND 
CRUDE EXTRACTS [106-110] 
 Chemical tests can be useful for the investigation of the chemical compounds and to 
observe the efficiency of an extraction process. The petroleum ether, chloroform, aqueous 
and methanol extracts were subjected to qualitative chemical tests. The various chemical tests 
performed on the extracts for steroids, terpenoids, flavones, anthraquinones, sugars, 
glycosides, alkaloids, quinones, phenols, tannins and saponins and the results were recorded. 
1.  Test for sterols 
      The powdered leaf was first extracted with petroleum ether and evaporated to a 
residue. Then the residue was dissolved in chloroform and tested for sterols. 
a. Salkowski’s Test 
 A few drops of concentrated sulphuric acid were added to the above solution, shaken 
well and set aside for while. The red color developing in the lower chloroform layer of the 
solution indicates the presence of sterols. 
b. Liebermann – Burchard’s Test 
 To the chloroform solution, a few drops of acetic anhydride and 1mL of concentrated 
sulphuric acid were added through the sides of the test tube and set aside. At the junction of 
two layers a brown ring was formed. The upper layer turns green indicates the presence of 
sterols.  
2.  Test for terpenoids  
A little of the powdered leaf was extracted with chloroform and filtered. The filtrate 
was warmed gently with tin and thionylchloride. A pink solution indicates the presence of 
terpenoids. 
                                                                              Phytochemical Evaluation 
 
Department of Pharmacognosy, MMC.  62 
3.  Test for carbohydrates 
     a. Molisch’s Test: To the aqueous extract of the powdered leaf, 2-3 drops of 1% alcoholic 
solution of α-naphthol and 2ml of concentrated sulphuric acid was added along the sides of 
the test tube. A purple colour indicates the presence of carbohydrates. 
    b. Fehling’s Test: To the aqueous extract of the powdered leaf, Fehling’s I and II solution 
was added and heated on a boiling water bath for half an hour. A red precipitate indicates the 
presence of free reducing sugars. 
   c. Benedict’sTest: To the aqueous extract of the powdered leaf, an equal volume of 
Benedict’s reagent was added. A red precipitate indicates the presence of reducing sugars.  
4. Test for proteins 
    a. Millon’s Test: A small quantity of acidulous – alcoholic extract of the powdered drug 
was heated with Millon’s reagent. A white precipitate turning red on heating indicates the 
presence of proteins. 
    b. Biuret Test:  To one portion of acidulous – alcoholic extract of the powdered drug, 1mL 
of 10% sodium hydroxide solution, followed by this one drop of dilute copper sulphate 
solution was added. A violet colour was formed indicating the presence of proteins. 
5. Test for flavonoids 
    a. Shinoda’s Test: To the little amount of the powdered drug, few magnesium turnings 
and few drops of concentrated hydrochloric acid were added and boiled for five minutes in a 
water bath. A red colour indicates the presence of flavonoids. 
    b. Alkali Test: To the small quantity of test solution, 10% aqueous sodium hydroxide 
solution was added.  A yellow orange colour indicates the presence of flavonoids. 
                                                                              Phytochemical Evaluation 
 
Department of Pharmacognosy, MMC.  63 
    c. Acid Test: A small quantity of test solution was treated with the few drops of 
concentrated sulphuric acid. A yellow orange colour indicates the presence of flavonoids. 
6.  Test for alkaloids 
About 2g of the powdered material was mixed with 1g of calcium hydroxide and 5mL 
of water into a smooth paste and set aside for 5 minutes. It was then evaporated to dryness in 
a porcelain dish on a water bath. To this 200mL of chloroform was added, mixed well and 
refluxed for half an hour on a water bath. Then it was filtered and the chloroform was 
evaporated. To this 5mL of dilute hydrochloric acid was added followed by 2mL of each of 
the following reagents. 
   a. Mayer’s Reagent: To small quantity of the extract add Mayer’s reagent. Cream 
precipitate indicates the presence of alkaloids.             
    b. Dragendorff’s Reagent: To small amount of the extract add Dragendroff’s reagent. 
Orange brown precipitate indicates the presence of alkaloids. 
    c. Hager’s Reagent: To small quantity of extract add Hager’s Reagent. Yellow precipitate 
indicates the presence of alkaloids. 
    d. Wagner’s Reagent: To small quantity of extract add Wagner’s reagent. Reddish brown          
precipitate indicates the presence of alkaloids. 
7.  Test for glycosides 
 Test for Anthraquinone glycosides 
Borntrager’s Test: The powdered leaf was boiled with dilute sulphuric acid, filtered and, 
benzene was added to the filtrate and shaken well. The organic layer was separated to which 
ammonia solution was added slowly. Pink colour in ammoniacal layer shows the presence of 
anthraquinone glycosides. 
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Modified Borntrager’s Test: About 0.1g of the powdered drug was boiled for 2minutes with 
dilute hydrochloric acid and few drops of ferric chloride solution were added, filtered while 
hot and cooled. The filtrate was then extracted with benzene and the benzene layer was 
separated. Equal volume of dilute ammonia solution was added to the benzene extract. Pink 
colour in ammoniacal layer shows the presence of anthraquinone glycosides. 
Test for cardiac glycosides (for deoxysugar) 
Keller Kiliani Test: About 1g of the powdered leaf was boiled with 10mL of 70% alcohol 
for 2min, cooled and filtered. To the filtrate 10mL of water and 5 drops of solution of lead 
subacetate were added and filtered, evaporated to dryness. The residue was dissolved in 3ml 
of glacial acetic acid. To this 2 drops of ferric chloride solution was added. Then 3 mL of 
concentrated sulphuric acid was added to the sides of the test tube carefully and observed.              
Reddish brown layer indicates the presence of deoxysugars of cardiac glycoside 
Test for cyanogenetic glycosides: A small quantity of the powder was placed in a stoppered 
conical flask with just sufficient water to cover it. A sodium picrate paper strip was inserted 
through the stopper so that it was suspended in the flask and it was set aside for 2h in a warm 
place. Brick red color produced on the paper indicates the absence of Cyanogenetic 
glycosides. 
8.  Test for saponins 
 Foam test: About 0.5g of the powdered drug was boiled gently for 2min with 20mL of water 
and filtered while hot and allowed to cool. 5mL of the filtrate was then diluted with water and 
shaken vigorously.  Frothing indicates the presence of saponins 
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9. Test for tannins  
           A small quantity of the powdered drug was extracted with water. To the aqueous 
extract few drops of ferric chloride solution was added. A bluish black colour indicates the 
presence of tannins. 
10. Test for the presence of Volatile oil 
Weighted quantity (250 gm) of fresh leaves were extracted the subjected to hydro 
distillation using volatile oil estimation apparatus. Volatile oil was obtained indicates the 
presence of volatile oil. 
11. Test for Mucilage 
A few mL of aqueous extract was prepared from the powdered drug was treated with 
ruthenium red. A pinkish red colour indicates the presence of mucilage. 
 12. Test for purine group (Murexide test) 
The residue obtained after the evaporation of chloroform as described above was 
treated with 1mL of hydrochloric acid in a porcelain dish and 0.1gm of potassium chlorate 
was added and evaporated to dryness on water bath. Then the residue was exposed to the 
vapour of dilute ammonia solution. Purple colour indicates the absence of purine group of 
alkaloids. 
13. Test for Coumarins  
       a.   FeCl3 test: To the alcoholic extract of the drug, few drops of alcoholic ferric chloride 
were added. The formation of deep green color turning yellow on addition of concentrated 
nitric acid indicates the presence of coumarins. 
       b.   Flourescence test: The alcoholic extract of crude extract was mixed with 1N sodium 
hydroxide solution. A blue-green fluorescence indicates the presence of coumarins. 
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The above chemical tests were carried out using leaf powder and different plant 
extracts and the results were tabulated in Tables 7 & 8 respectively. The results obtained for 
the qualitative chemical tests using leaf powder was presented in Table 7.  
SECTION B - QUANTITATIVE ESTIMATION OF PHYTOCONSTITUENTS[111-118] 
             In quantitative estimations, a particular group of compound present in the crude 
extracts can be quantified by means of using standard or reference marker compound and 
then reporting them as equivalent to that much amount of compound present in that extract as 
per standard compound. 
Estimation of total phenolic content  
Phenol constitutes the largest group of plant secondary metabolites. Phenols are 
widespread in nature and are important constituents of medicinal plants. They range from 
simple structures with one aromatic ring to highly complex polymeric substances such as 
tannins, flavonoids, anthraquinones and coumarins. Phenolic substances are water soluble 
and they have been reported to have multiple biological effects, including antioxidant 
activity.  
Principle 
The total phenolic content of the methanolic extract of Costus pictus D. Don (MECP) 
and methanolic extract of Costus pictus D. Don silver nanoparticles (MECPAgNPs) was 
determined by Folin-Ciocalteau reagent. This reagent consists of phosphotungstic acids and 
phosphomolybdic acids mixture. While phenolic content of the extract was oxidized, this 
reagent is reduced to the mixture of blue molybdenum and tungsten oxides. The intensity of 
colour is proportional to the amount of phenolic content of the extract and which was 
measured at 765nm. The total phenolic content in MECP & MECPAgNPs was expressed as 
milligrams of gallic acid equivalent (GAE) per gm of extract.  
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Reagents  
a) A stock solution of methanolic extract of Costus pictus D. Don and methanolic extract 
of Costus pictus D. Don silver nanoparticles (1mg/mL).  
b) Folin Ciocalteu Reagent (1N) 
Commercially available Folin Ciocalteu Reagent (2N) was diluted with an equal 
volume of distilled water. The resultant solution was kept in an amber coloured bottle 
and stored in refrigerator at 4ºC. 
c) Sodium carbonate solution (10%w/v) 
Procedure 
0.5mL and 1mL of the MECP & MECPAgNPs was taken in 10mL volumetric 
flaskstube. To this, 0.5mL of Folin Ciocalteu reagent (1N) was added and allowed to stand 
for 15min. Then 1mL of 10% sodium carbonate solution was added. Finally the mixture was 
mixed with distilled water and made upto10mL, allowed to stand for 30min at room 
temperature and total phenol was determined by spectrophotometrically at 760nm. The 
reaction mixture without sample was used as blank. The calibration curve of concentration 
versus absorbance was generated for gallic acid at different concentrations (2, 4, 6, 8, 
10µg/mL) which was used as a standard (Fig. 20). The amount of phenol present can be 
determined by linear regression analysis. The total phenol content of MECP & MECPAgNPs 
were expressed in terms mg of gallic acid equivalent/g of extract (mg GAE/g) and the results 
obtained are presented in Table 9. 
Total flavanoid content estimation 
 The word “Flavonoid” is derived from the Latin word flavus which means yellow. 
Most of the flavonoids are indeed yellow in colour. They are widely distributed in nature. It 
consists of one benzene–gamma – pyrone structure. They have ability to complex with metal 
                                                                              Phytochemical Evaluation 
 
Department of Pharmacognosy, MMC.  68 
ions and act as an antioxidants and bind to proteins such as structural proteins and enzymes. 
The different classes with in the groups are distinguished by additional oxygen containing 
heterocyclic rings and hydroxyl groups which includes flavones, flavanones, flavonols, 
isoflavones, catechin, anthocyanidins, leuco anthocynadins, chalcones and aurones. 
Principle 
The aluminium chloride colorimetric technique was used for estimation of total 
flavonoid content. The aluminium ions form stable complexes with C4 keto group and either 
to C3 or C5 hydroxyl groups of flavones and flavonols in acidic medium. It also forms acid 
labile complexes with ortho hydroxyl groups in the A or B rings of flavonoids. The intensity 
of the colour is proportional to the amount of flavonoids and can be estimated as quercetin 
equivalent at wavelength of 415nm.  
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents  
a) A stock solution of  methanolic extract of Costus pictus D. Don and methanolic 
extract of Costus pictus D. Don silver nanoparticles (1mg/mL) 
b) 10% aluminum chloride 
c) 1M potassium acetate 
d) 95%v/v ethanol 
Procedure 
An aliquot quantity of quercetin was dissolved in ethanol to get a stock solution of 
1mg/mL. Further dilutions were made to get concentrations ranging from 20-100µg/mL. 1ml 
of the above standard solutions were taken in different volumetric flasks, 0.1mL of aluminum 
chloride solution, 0.1mL of potassium acetate solution and 2.8mL of ethanol were added and 
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the final volume was then made up to 5mL with distilled water. After 20min the absorbance 
was measured at 415nm. A sample without aluminium chloride was used as a blank. From 
the absorbance obtained, a calibration curve was constructed by plotting concentration versus 
absorbance of quercetin (Fig. 21). 0.5mL and 1mL of MECP & MCPEAgNPs of sample at 
concentrations 100µg/mL and 200µg/mL were taken and the reaction was carried out as 
above and the absorbance was measured at 415nm after 20min and the readings were 
tabulated in Table 10. The amount of flavonoids present was determined by linear regression 
analysis. The total flavonoid content in MECP & MCPEAgNPs was expressed as mg of 
quercetin equivalents per gram of extract. 
Estimation of total tannin content   
 The term “tannin” was first applied by Seguin in 1796. Tannins are complex organic, 
non–nitrogenous plant products, which generally have astringent properties. These 
compounds comprise large group of compounds that are widely distributed in the plant 
kingdom. Most of the tannins are high molecular weight compounds. They are complex 
polyphenolics, which are polymerisation of simple polyphenols. 
Principle  
 Total tannin content of extract was determined by Folin Denis reagent method. This is 
based on the stoichiometric oxidation of the molecules containing a phenolic hydroxyl group.                
Tannin like compounds reduces phosphotungstomolybdic acid in alkaline solution to produce 
a highly coloured blue solution. The intensity of which is proportional to the amount of 
tannins and it was estimated by spectrophotometer at 700 nm. 
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
 
                                                                              Phytochemical Evaluation 
 
Department of Pharmacognosy, MMC.  70 
Reagents  
a) A stock solution of  methanolic extract of Costus pictus D. Don and methanolic 
extract of Costus pictus D. Don silver nanoparticles (1mg/mL) 
b) Folin-Denis Reagent: Sodium tungstate 100g and phosphomolybdic acid 20g 
were dissolved in distilled water 750mL along with phosphoric acid 50mL. The 
mixture was refluxed for 2h and volume was made up to 1L with distilled water. 
c) Sodium carbonate solution (10%) 
Procedure 
             0.1mL and 0.2mL of (1mg/ml) methanolic extracts of MECP & MECPAgNPs was 
made upto1mL with distilled water in 10mL volumetric flasks. To this, 0.5mL of Folin Denis 
reagent and 0.8mL of distilled water was added. The flasks were allowed to stand for 15min, 
then 1mL of sodium carbonate solution (10%) was added to the above mixture and it was 
made up to 10mL with distilled water. The mixture was allowed to stand for 30min at room 
temperature and the tannin content was determined spectrophotometrically at 700nm. The 
reaction mixture without sample was used as blank. Tannic acid at different concentrations 
(4, 8, 12, 16 & 20µg/mL) was subjected to the above procedure and absorbance noted. A 
calibration curve was generated by plotting concentration versus absorbance (Fig. 22). A 
linear regression equation was constructed using the calibration curve. The amount of tannin 
content present can be determined by linear regression analysis. The total tannin content in 
the MECP & MECPAgNPs was expressed as milligrams of tannic acid equivalent per gm of 
extract. The results were tabulated in Table 11. 
Estimation of vitamin C [119-125] 
 Vitamin C is also known as L-ascorbic acid is a water-soluble vitamin. It is required 
for the biosynthesis of collagen, L-carnitine, and certain neurotransmitters. It is also involved 
                                                                              Phytochemical Evaluation 
 
Department of Pharmacognosy, MMC.  71 
in protein metabolism. Collagen is an essential component of connective tissue, which plays a 
vital role in wound healing. Vitamin C is also an important physiological antioxidant and has 
been shown to regenerate other antioxidants within the body, including alpha-tocopherol 
(vitamin E) .Vitamin C might help to prevent or delay the development of certain cancers, 
cardiovascular disease, and other diseases in which oxidative stress plays a causal role. In 
addition to its biosynthetic and antioxidant functions, vitamin C plays an important role in 
immune function and improves the absorption of nonheme iron, the form of iron present in 
plant-based foods.  
Fruits and vegetables are the best sources of vitamin C. Citrus fruits, tomato, amla . 
Other good food sources include red and green peppers, kiwifruit, broccoli, strawberries, 
Brussels sprouts, and cantaloupe. Insufficient vitamin C intake causes scurvy, which is 
characterized by fatigue or lassitude, widespread connective tissue weakness and capillary 
fragility.  
Principle 
 The estimation of Vitamin C was carried out using the method of Sarojini et al., with 
slight modifications. The keto group of ascorbic acid undergoes a condensation reaction with 
2, 4 dinitro phenyl hydrazine to form a hydrazone which is orange yellow and has an 
absorbance of about 520nm. 
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents  
a) A stock solution of methanolic extract of Costus pictus D. Don and methanolic      
extract of Costus pictus D. Don silver nanoparticles (1mg/mL) 
          b) 2, 4-dinitro phenyl hydrazine (0.2%) 
          c) 85% sulphuric acid 
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Procedure  
Ascorbic acid was weighed and dissolved in water to get stock solution of 1mg/mL. 
Further dilutions were made to get the concentrations ranging from 40-200µg/mL. To 1mL of 
sample, 0.5mL of 2, 4-dinitro phenyl hydrazine solution was added and incubated for 3h at 
37ºC. After 3h, 2.5mL of 85% sulphuric acid was added and the absorbance was measured 
after 30min at 520nm. A calibration curve was constructed by plotting concentration versus 
absorbance of ascorbic acid (Fig. 23). The procedure was repeated for the MECP & 
MECPAgNPs as above and the absorbance was measured at 520nm after 3h and the readings 
were tabulated in Table 12. The amount of vitamin C present can be determined by linear 
regression analysis. The vitamin C content was expressed as mg/g of extract. 
SECTION C – CHROMATOGRAPHY [126-129] 
Chromatography methods are important analytical tool in the separation, 
identification and estimation of different components present in crude plant mixture or 
extract. There are different types of chromatography namely paper chromatography, thin 
layer chromatography, gas chromatography, high performance thin layer chromatography and 
high performance liquid chromatography etc. 
THIN LAYER CHROMATOGRAPHY 
Thin layer chromatography is a simple, quick and inexpensive method. It is also 
called planer chromatography. 
Principle 
 Thin layer chromatography is a technique used for the separation, identification and 
estimation of single or mixture of components present in the various extracts. It is reliable 
technique in which solute undergoes distribution between two phases, stationary and mobile 
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phase. The separation is mainly based on the differential migration that occurs when a solvent 
flows along the thin layer of stationary phase. This may be achieved by partition and 
adsorption depending on stationary phase used.[126] 
TLC Plate preparation 
 The plates were prepared using TLC Spreader. 40 gm of silica G was mixed with 85 
ml of water to prepare homogenous suspension and poured in the spreader. 0.25mm thickness 
of plates was prepared and air dried. Then, the dried plates were kept at 1100C for 30 mins 
and kept in dessicators.[127] 
Selection of mobile phase 
 Solvent mixture was selected on the basis of the phytoconstituents present in each 
extract. Solvents were analysed in the order of increasing polarity. Factors such as nature of 
components, stationary phase and mobile phase polarity influence the rate of separation of 
constituents. 
 Several mobile phases were tried for the separation of maximum components. From 
the vast analysis, best solvent was selected which showed good separation with maximum 
number of components.[128] 
Solvent System 
Toulene: ethyl acetate: methanol (5:3:2) 
Detection 
 Visual and UV light at 254 & 366nm 
The Rf Value of the spots obtained were calculated using the following formula; 
 Rf Value = Distance travelled by the solute 
                              Distance travelled by the solvent  
The results obtained for the TLC analysis is presented in the Table 13 & Fig. 24. 
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HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY 
 
  
HPTLC is a sophisticated and automated form of TLC. HPTLC is a reliable method 
for separation of nanogram amount even when present in complex formulation. It is 
extremely flexible, reliable and cost efficient method in determining the number of 
ingredients in the mixture. 
Basic steps involved in HPTLC are:  
Instrument used:  CAMAG TLC Scanner 3 "Scanner3-070408"S/N 070408(1.41.21) was 
used for detection and CAMAG Linomat 5 sample applicator was used for the application of 
the track. Twin trough plate development chamber was used for development of 
chromatogram. Software used was winCATS 1.4.3 
 Sample: The methanolic extract of Costus pictus D. Don was dissolved in methanol to get a 
concentration of 10mg/mL and 2μL of this solution was used for taking HPTLC fingerprint.  
Stationary Phase: Aluminium sheets pre-coated with silica gel Merck G F254, 0.2mm layer 
thickness were used as the stationary phase.  
Mobile phase: Toluene: ethyl acetate: methanol (5:3:2) was used as the mobile phase for 
development of chromatogram. The mobile phase was taken in a CAMAG twin trough glass 
chamber. 
Detection wavelength: The developed plates were examined at wavelength 254nm and 
366nm in Densitometry TLC scanner3. The TLC visualization, 3D display of the finger print 
profile and peak display at 254nm and 366nm are presented in Figs. 25 to 29.  
The Rf values and area under curve for each peak of are presented in Table 14. 
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RESULTS AND DISCUSSION 
SECTION A - QUALITATIVE CHEMICAL TESTS FOR THE LEAF POWDER AND 
CRUDE EXTRACTS 
The results obtained for the preliminary phytochemical screening of the powder is 
presented in Table 7.  
Table 7:  Preliminary phytochemical screening for the powder of Costus pictus D. Don 
 
S. 
No 
                               Test Results 
1. TEST FOR STEROLS  
 a. Salkowski’s test + 
 b. Libermann- burchard’s test + 
2. TEST FOR TERPENOIDS + 
3. TEST FOR CARBOHYDRATES + 
 a.Molisch’s test + 
 b. Fehling’s test  
 c. Benedict’s test + 
4. TEST FOR PROTEINS + 
 a. Millon’s test  
 b. Biuret test + 
5. TEST FOR FLAVONOIDS + 
 a. Shinoda test + 
 b. Alkali test + 
 c.Acid test  
6. TEST FOR ALKALOIDS  
 a. Mayer’s reagent + 
 b. Dragendroff’s reagent + 
 c. Hager’s reagent + 
 d. Wagner’s reagent + 
7. TEST FOR GLYCOSIDES  
 a. Anthraquinone glycosides - 
     i) Borntrager’s test - 
     ii) Modified Borntrager’s test - 
 b. Cardiac glycosides + 
     i) Keller Killiani test  + 
  c. Cyanogenetic glycosides - 
8. TEST FOR SAPONINS  
 Foam test + 
9. TEST FOR TANNINS  
 a.FeCl3 test  + 
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10. TEST FOR VOLATILE OIL + 
11. TEST FOR MUCILAGE + 
12. TEST FOR PURINES - 
13. TEST FOR COUMARINS + 
                                 (+) indicates positive reaction     (-) indicates negative reaction                      
 
From the table, it can observed that the powder showed the presence of phytosterols, 
proteins, carbohydrates, phenolic compounds, alkaloids, flavonoids, cardiac glycosides. It 
showed absence for cyanogenetic glycosides, anthroquinone glycosides and purines. 
The results obtained for the preliminary phytochemical screening of the various 
extracts are presented in Table 8. 
Table 8: Preliminary phytochemical screening of 
various extracts of  leaf powder of Costus pictus D. Don 
 
S. No Chemical Tests MethanolExtract 
Chloro 
form  
extract 
Aqueous 
Extract 
1. Test For Sterols 
 a. Salkowski’s test + + - 
 b.Libermann-Burchard’s test + + - 
2. Test for carbohydrates 
 a. Molisch’s test + - + 
 b. Fehling’s test + - + 
 c. Benedict’s test + - + 
3. Test for protein 
 a. Millon’s test + - + 
 b. Biuret test + - + 
4. Test for Alkaloids 
 a.Mayer’s reagent + + - 
 b. Dragendroff’s reagent + + - 
 c. Hager’s reagent + + - 
 d. Wagner’s reagent + + - 
 e. Test for purine group (Murexide 
test ) 
- - - 
5. Test for glycosides 
 a. Anthraquinone glycosides    
 i) Borntrager’s test - - - 
 ii) Modified Borntrager’s test - - - 
 b. Cardiac glycosides    
 i) Keller Killiani test + - - 
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 ii) Baljet test + -  
 iii) Cyanogenetic glycosides - - - 
6. Test for Saponins + - + 
7. Test for Tannins    
 i) FeCl3 test + - + 
 ii) Lead acetate test + - + 
8. Test for Flavonoids    
 a. Shinoda test + - - 
 b. Alkali test + - - 
9. Test for Terpenoids + + - 
10. Test for Fixed Oils - - - 
11. Test for Mucilage + - + 
   (+) indicates positive reaction                 (-) indicates negative reaction 
From the Table 8, it can observed  that the aqueous extract of the Costus pictus D. 
Don showed the presence of flavonoids, tannins, saponins, proteins and carbohydrates while 
the methanolic extract of Costus pictus D. Don showed the presence of flavonoids, phenolic 
compounds, alkaloids, cardiac glycosides, protein and carbohydrates. The chloroform extract 
of Costus pictus D. Don showed the presence of terpenoids, alkaloids 
SECTION B – QUANTITATIVE ESTIMATION OF PHYTOCONSTITUENTS 
Estimation of total phenolic content 
The results for the total phenolic content of MECP & MECPAgNPs are tabulated in Table 9. 
Table 9: Total phenolic content in MECP & MECPAgNPs 
in terms of gallic acid equivalents 
 
Conc. 
of 
gallic 
acid 
in 
µg/mL 
Absorbance 
at 
760nm 
Conc. of 
ethanolic 
extract 
in 
µg/mL 
 
Absorbance at 760nm* 
 
 
Amount of total phenolic 
content in terms 
mgGAE/g of extract* 
MECP MEAgNPs MECP MEAgNP 
2 0.229 ± 0.010 50 0.530±0.001 0.542±0.002 92.06±1.2 94.13±0.3 
4 0.452 ± 0.006 100 0.980±0.008 0.991±0.001 84.82±0.5 85.77±0.8 
6 0.695 ± 0.005  
Average 88.44±0.85 90±0.55 8 0.918 ± 0.031  
10 1.162 ± 0.028  
* mean of three readings ±SEM 
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Fig.20: Calibration curve of gallic acid 
 
The linear regression equation was found to be y = 0.116x-0.004 while the correlation 
was found to be 0.9998. The amount of phenolic content present in the MECP & 
MECPAgNPs  in terms mg GAE/g of extract was found to be 88.44±0.85 & 90±0.55 by 
using the above linear  regression equation. 
Estimation of total flavonoid content 
The results for total flavonoid content of MECP & MECPAgNPs are presented in 
Table 10.    
Table 10: Total flavonoid content in MECP & MECPAgNPs per gram of  in terms of 
quercetin by aluminium chloride method 
 
Conc. 
of 
quercet
in in 
µg/mL 
Absorbance 
at 
415nm 
Conc. 
of  
extract 
in 
µg/mL 
 
Absorbance at 415nm* 
 
 
Amount of total flavonoid 
content in terms mgQE/g 
of extract* 
MECP MEAgNPs MECP MEAgNPs 
20 0.589 ± 0.01 100 0.337±0.011 0.35±0.011 115.96±0.26 117.45±0.37 
40 1.151 ± 0.04 200 0.669±0.017 0.65±0.017 123.76±3.69 128.07±0.37 
60 1.710 ± 0.09  
Average 119.86±1.97 122.76±0.37 80 2.390 ± 0.03  
100 3.112 ± 0.03  
* mean of three readings ±SEM 
Calibration curve of gallic acid
y = 0.116x - 0.004
R2 = 0.9998
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Calibration curve of quercetin
y = 0.0307x - 0.0432
R2 = 0.9974
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                                                 Fig. 21:  Calibration curve of quercetin 
 
 
 
 
 
 
 
 
The linear regression equation was found to be y = 0.0307x-0.0432 while the 
correlation was found to be 0.9974. The amount of flavonoid content present in the MECP & 
MECPAgNPs in terms mg quercetin equivalent/g of extract was found to be 119.86±1.97 & 
122.76±0.37mg/g of extract by using the above linear regression equation. 
Estimation of total Tannin Content: 
The results for total tannin content of MECP & MECPAgNPs are presented Table 11. 
Table 11: Total tannin content in MECP & MECPAgNPs in terms of tannic acid                              
equivalents 
 
Conc. 
of 
Tannic 
acid in 
µg/mL 
Absorbance 
at 
700nm 
Conc. 
of 
extract 
in 
µg/mL 
 
Absorbance at 700nm* 
 
 
Amount of total Tannin 
content in terms mg tannic 
acid/g of extract* 
MECP MEAgNPs MECP MEAgNPs 
4 0.098 ± 0.02 10 0.059±0.015 0.07±0.002 246.42±5.15 295.40±9.16 
8 0.183 ± 0.01 20 0.140±0.008 0.145±0.005 304.75±1.96 316.66±2.68 
12 0.203 ± 0.01  
Average 275.58±3.55 306.03±13.8416 0.361 ± 0.20  
20 0.415 ± 0.10  
* mean of three readings ±SEM 
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Fig-.22: Calibration curve for tannic acid             
 
         Total tannin determination is carried out by spectrophotometry after oxidation of the 
analyte with the Folin–Denis reagent in alkaline medium. This method is based on a redox 
reaction and other reducing agents in the samples. The linear regression equation was found 
to be y = 0.022x + 0.003 while the correlation was found to be 0.999. The amount of tannin 
content present in the MECP & MECPAgNPs in terms of  mg tannic acid/g of extract was 
found to be  275.58±3.55 & 306.03±13.84 by using the above linear regression equation. 
Estimatin of Vitamic C Content 
The results for vitamin C content of MECP & MECPAgNPs are presented in Table 
12.  
Table 12:  Vitamin C content in MECP & MECPAgNPs 
 
Conc. 
of 
ascorbi
c acid 
in 
µg/mL 
Absorbance 
at 
520nm 
Conc. 
of ext. 
in 
µg/mL 
 
Absorbance at 520nm* 
 
Amount of Vitamin C 
present/g of extract* 
MECP MEAgNPs MECP MEAgNPs 
40 0.135 ± 0.000 
50 0.0866±0.012 0.094±0.066 746.66±12.01 830.04±10.03 
80 0.265 ± 0.015 
120 0.346 ± 0.010 
160 0.468 ± 0.011 
200 0.525 ± 0.010 
* mean of three readings ±SEM 
y = 0.0224x + 0.0038 
R² = 0.9997 
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y = 0.0027x + 0.012 
R² = 0.9982 
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Fig. 23: Calibration curve of ascorbic acid 
 
 
 
 
 
  
 
  
The linear regression equation was found to be y = 0.0027x + 0.012 and a correlation 
Coefficient was 0.9982. The amount of vitamin C content present in the MECP & 
MECPAgNPs was found to be 746.66±12.01 & 830.04±10.03 mg/gm of extract by  using the 
above linear regression equation.  
SECTION C - CHROMATOGRAPHY 
THIN LAYER CHROMATOGRAPHY 
 The results obtained for the TLC analysis with mobile phase is presented in 
the Table 13. The extract showed 5 spots at visible light and 4 spots at 254nm. The Rf value 
0.50 when viewed under visible light after development in the mobile phase namely toulene: 
ethyl acetate: methanol (5:3:2) was dark green which may be due the presence of flavonoid 
compounds. The Rf values indicating the MECP contains many medicinally active 
compounds which may be responsible for the therapeutic activity. 
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CHAPTER 8 
PHARMACOLOGICAL EVALUATION 
 
The word pharmacology is derived from Greek words pharmacon (an active principle) 
and logos (a discourse or treatise). Pharmacology is the study of drugs and their effects on 
life processes. It is a fundamental science that sprang to the forefront of modern medicine 
with demonstrated success in treating diseases and saving lives. 
The evaluation of the therapeutic potential of a drug needs to be conducted in a 
systemic manner. The MECP and MECPAgNPs were subjected to pharmacological screening 
namely antioxidant and antidibetic activity. 
MATERIALS & METHODS 
SECTION A – In- vitro ANTIOXIDANT ACTIVITY [130-138] 
 Antioxidants protects the cell against the damaging effects of reactive oxygen species, 
such as singlet oxygen, super oxide, peroxyl radicals, hydroxyl radicals and peroxynitrite 
which results in oxidative stress leading to cellular damage. They scavenge free radicals 
generated during oxidative stress and exhibit a protective effect against many diseases like 
diabetes, cancer, cardiovascular diseases and ageing.  The plants contain a wide variety of 
free radical scavenging molecules such as flavonoids, phenols, terpenoids and vitamins. The 
natural antioxidants are ascorbic acid, vitamin E, phenolic acids etc. Natural antioxidants tend 
to be safer, therefore the evaluation of antioxidant activity of various plant extracts is 
considered as an important step in the identification of their ability to scavenge the free 
radicals. 
 Some of the in vitro models for the evaluation of antioxidant activity are listed below; 
 DPPH assay 
 Superoxide scavenging assay 
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 Hydroxyl radical scavenging assay 
 Nitric oxide radical inhibition assay 
 Reducing power assay 
 Phosphomolybdenum method 
 Peroxy nitrile radical scavenging activity 
 Xanthine oxidase method  
 Ferric reducing ability of plasma 
 Thiobarbituric acid assay 
Method 1: Free radical Scavenging activity using diphenyl picryl hydrazyl (DPPH)  
 
The free radical scavenging activity of the extracts is evaluated by assessing their 
ability to reduce the colour of DPPH in ethanol according to Brand Williams. DPPH stable 
free radical method is an easy, rapid and sensitive way to survey the antioxidant activity of 
specific compound or plant extracts. [131,132] 
Principle 
A simple method that has been developed to determine the antioxidant activity of 
plants utilizes the stable 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical. The odd electron in 
the DPPH free radical gives a strong absorption maximum at 517nm and is purple in color.  
The color turns from purple to yellow as the molar absorptivity of the DPPH radical at 51 nm 
reduces from 9660 to 1640 when the odd electron of DPPH radical becomes paired with 
hydrogen from a free radical scavenging antioxidant to form the reduced DPPH-H.  The 
resulting decolorization is stoichiometric with respect to number of electrons captured. [132] 
    DPPH. + AH   DPPH – H + A. 
Instrument 
Shimadzu UV Visible spectrometer, Model 1800 
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Reagents 
0.1mM Diphenyl Picryl Hydrazyl Radical in ethanol 
Procedure  
A stock solution of 0.5mg/mL concentration of MECP & MECPAgNPs was prepared. 
To the 1mL of various concentrations of test samples, 4mL of DPPH was added. Control was 
prepared without sample in an identical manner. DPPH was replaced by ethanol in case of 
blank. The reaction was allowed to be completed in the dark for about 30min. Then the 
absorbance was measured at 517nm. Vitamin C was used as standard. The percentage 
scavenging was calculated using the formula [(Control-Test)/Control] x 100. A graph was 
constructed by plotting concentration versus percentage inhibition and a linear regression 
equation calculated. The concentration of the sample required for 50% reduction in 
absorbance (IC50) was calculated using linear regression analysis.  A triplicate reading was 
taken and average was calculated.  The results obtained are presented in Table 15 and Fig. 
30.  
Method 2: Determination of scavenging activity against hydrogen peroxide [136] 
Principle  
 Hydrogen peroxide is a weak oxidizing agent and can inactivate a few enzymes 
directly, usually by oxidation of essential thiol (-SH) groups. Hydrogen peroxide probably 
reacts with Fe2+ and possibly Cu2+ to form hydroxyl radical and this may be the origin of 
many of its toxic effects. It is therefore biologically advantageous for cells to control the 
amount of hydrogen peroxide that is allowed to accumulate. 
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
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Reagents 
6% hydrogen peroxide diluted with water in the ratio of 1:10 
0.1M phosphate buffer pH 7.4 
Procedure 
            The MECP & MECPAgNPs was dissolved in ethanol to get a stock solution 
containing 1mg/mL. Varying quantities of the stock solution were added to 3.8mL of 0.1M 
phosphate buffer solution (pH 7.4) and then 0.2mL of hydrogen peroxide solution was added 
and the absorbance was measured at 230nm after 10min. The reaction mixture without 
sample was used as blank. Ascorbic acid was used as standard. The percentage inhibition of 
hydrogen peroxide was calculated using the formula   =   (A control – A sample) / A control x 100. 
The concentration of extract to produce 50% inhibition was found using linear regression 
analysis. The results obtained are presented in Table 16 and Fig. 31. 
Method 3: Total antioxidant activity by Phosphomolybdenum Method [135] 
 
Principle 
 
            Total antioxidant capacity was measured by spectrophotometric method of prieto et 
al. Phosphomolybdenum method assay is based on the reduction of Mo (VI) to Mo (V) by the 
sample analyte and the subsequent formation of green phosphate Mo (V) complex at acidic 
pH and the absorbance was measured at 695nm. This method is used to determine the total 
antioxidant activity of samples.  
Mo6+         →        Mo5+ 
Reagents 
 
0.6M sulphuric acid 
28mM sodium phosphate 
4mM   ammonium molybdate 
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Instrument 
 
 Shimadzu UV Visible spectrophotometer, Model 1800 
 
 Procedure 
 
  An aliquot of 0.3mL of different concentrations of MECP & MECPAgNPs was 
combined with 2.7mL of the reagent solution (H2SO4, sodium phosphate and ammonium 
molybdate). In case of blank, 0.3mL of ethanol was used in place of sample. The tubes were 
incubated for 95°C for 90min. After the mixture was cooled to room temperature, the 
absorbance was measured at 695nm against blank. The standard Ascorbic acid was treated in 
a similar manner. The total antioxidant activity is expressed as the number of equivalents of 
ascorbic acid (µg/g). The results were tabulated in Table 17 and the graphical representation 
is presented in Fig. 32. 
Method 4: Ferric Reducing Antioxidant Power (FRAP) Assay [135] 
Total antioxidant activity is measured by FRAP assay of Benzie et al., (1999). The 
ferric reducing antioxidant power assay measures the potential of antioxidants to reduce the 
Fe3+ and 2,4,6 tripyridyl-s-triazyne (TPTZ) complex present in stoichiometric excess to the 
blue coloured Fe2+ complex which increases the absorption at 593nm. 
Principle  
At low pH, reduction of ferric tripyridyl triazine (Fe III TPTZ) complex to ferrous 
form (which has an intense blue colour) can be monitored by measuring the change in 
absorption at 593nm. The reaction is non specific, in that any half reaction that has lower 
redox potential, under reaction conditions, than that of ferric ferrous half reaction, will drive 
the ferrous (Fe III to Fe II) ion formation. The change in absorbance is therefore, directly 
related to the combined or “total” reducing power of the electron donating antioxidants 
present in the reaction mixture.  
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Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents  
FRAP Reagent  
a) Acetate buffer 30mM pH 3.6: Weigh 3.1g sodium acetate trihydrate and add 16 ml 
of glacial acetic acid and make the volume to 1 L with distilled water. 
b)  TPTZ (2, 4, 6-tripyridyl-s- triazine) (M.W. 312.34) 10mM in 40mM HCl 
c)  FeCl3. 6H2O (M.W. 270.30) 20mM 
The working FRAP reagent was prepared freshly by mixing a, b & c in the ratio of    
10:1:1 at the time of use.  
Procedure  
 50µL, 100µL, 150µL, 200µL, 250µL, 300µL of 1mg/mL concentration of MECP & 
MECPAgNPs were taken and mixed with 3mL of working FRAP reagent and absorbance 
was measured at 0min after vortexing at 593nm. Thereafter samples were placed at 37ºC in 
water bath and absorption was again measured after 4min. Ascorbic acid was used as 
standard. The FRAP value of the sample was calculated using this equation: [Change in 
absorbance of sample from 0-4min/change in absorbance of standard from 0-4min] * Frap 
value of standard. The result obtained for the FRAP assay are presented in the Table 18 and 
Fig. 33. 
Method 5:  Reducing power assay [130] 
Principle 
 The reducing power assay is a spectrometric method and is based on the principle that 
an increase in absorbance of the reaction mixture as concentration increase indicates an 
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increased antioxidant activity. It is based on the reduction of ferric in potassium ferricyanide 
to ferrous to form potassium ferrocyanide by the sample and the formation of Prussian blue 
colour complex when treated with ferric chloride. The absorbance of the blue complex when 
treated with ferric chloride is measured at 700nm. 
Instrument 
Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents 
 1% Potassium ferricyanide 
 10% Trichloro acetic acid. 
 0.2M, pH 6.6 phosphate buffer 
 0.1% ferric chloride. 
Procedure 
 About 0.5mL of various concentration of MECP, MECPAgNPs was mixed with 
0.75mL phosphate buffer and 0.75mL potassium ferricyanide [K3 Fe(CN6)], then the mixture 
was incubated at 50◦C for 20min. 0.75mL of trichloro acetic acid was added to the mixture, 
which was then centrifuged at 3000rpm for 10min. Finally 1.5mL of the supernatant solution 
was mixed with 1.5mL of distilled water and 0.1mL of ferric chloride (FeCl3) and absorbance 
was measured at 700nm in a UV-Visible Spectrophotometer. Ascorbic acid was used as 
standard and phosphate buffer used as blank. The absorbance of the final reaction mixture of 
three parallel experiments was expressed as mean ± standard error of mean. Increased 
absorbance of the reaction mixture indicates stronger reducing power. The results obtained 
are tabulated in Table 19 and the graphical representation is presented in Fig. 34.  
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SECTION B – In- vitro ANTIDIABETIC ACTIVITY [139-166] 
Diabetes is well-known to result in long-term health disorders including 
cardiovascular disease and blindness. These patients would require the development of 
several medications with multiple modes of actions. One of the major challenges in the 
management of diabetes is the monitoring of glucose concentrations. Despite intensive efforts 
no method is currently available for the continuous non-invasive monitoring of blood 
glucose. [139-140]. 
Nanotechnology is a focal point in diabetes research, where nanoparticles in particular 
are showing great promise in improving the treatment and management of the disease. Due to 
their ability to potentially enhance drug delivery to areas where there are barriers or 
unfavourable environments for macromolecules, nanoparticles are being explored as vehicles 
for improved oral insulin formulations. The use of nanotechnology in the development of 
glucose sensors is also a prominent focus in non-invasive glucose monitoring systems. There 
are a few limitations in the use of conventionally available drug delivery systems as 
pharmacological agents in disease treatment as there is lack of target specificity, altered 
effects and diminished potency due to drug metabolism in the body. [141,142] 
Metallic nanostructures have been studied extensively and are emerging as important 
colorimetric reporters due to their high extinction coefficients, which are typically several 
orders of magnitude larger than those of organic dyes. Many researches demonstrated the role 
of metals in glucose metabolism and the association of their deficiency with diabetes. In 
particular, nanostructures made from the noble metal silver, with their associated strong 
plasmon resonance, have generated great interest.  
 The in vitro antidiabetic activity of the methanolic leaf extract of Costus pictus silver 
nanoparticles synthesized was compared with the methanolic leaf extract of Costus 
pictus.was carried out.  
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             The in vitro antidiabetic activity was carried out using the following methods; 
 Non – enzymatic glycosylation of haemoglobin assay 
 Inhibition of alpha glucosidase enzyme assay 
 Inhibition of alpha amylase enzyme assay 
 Glucose uptake by yeast cells. 
METHOD 1: NON ENZYMATIC GLYCOSYLATION OF HAEMOGLOBIN 
ASSAY[143-153] 
 
Glycated hemoglobin (Hemoglobin A1c, A1C, or Hb1c; sometimes also HbA1c) is a 
form of haemoglobin that is measured primarily to identify the average plasma glucose 
concentration over prolonged periods of time The amount of glycated hemoglobin should not 
be more than 12%. In Diabetes mellitus, higher amounts of glycated hemoglobin, indicating 
poorer control of blood glucose levels, have been associated with cardiovascular disease, 
nephropathy, and retinopathy. Monitoring HbA1c in type 1 diabetic patients may improve 
outcome of treatment. 
Principle 
 Glycation of proteins is a frequent occurrence, but in the case of hemoglobin, a non 
enzymatic reaction occurs between glucose and the N-end of the beta chain. This forms a 
Schiff base which is itself converted to 1-deoxyfructose. This rearrangement is known as 
Amadori rearrangement. When blood glucose levels are high, glucose molecules attach to the 
hemoglobin in red blood cells. The longer hyperglycemia occurs in blood, the more glucose 
binds to hemoglobin in the red blood cells and higher the glycated hemoglobin Fig. 35. 
Glucose levels are intermittently raised in portal vessels carrying absorbed glucose to the 
liver for regulation. Passing red cells will have increased glycation after sugary food intake. 
Once a hemoglobin molecule is glycated, it remains that way. A buildup of glycated 
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Procedure  
Non – enzymatic glycation of haemoglobin assay was assessed using modified 
method previously described by Bhoomi B. Joshi et al., 2013. The MECP, MECPAgNPs and 
α-tocopherol was dissolved separately in DMSO to get a stock solution of 1mg/mL. To 
various concentrations of the stock solution (200-1000µg/mL), 1mL of glucose solution, 1mL 
of haemoglobin solution and 1mL of gentamycin (20 mg/100 mL) in 0.01M phosphate buffer 
(pH 7.4) was added. The mixture was then incubated in dark at room temperature for 72 h. α-
tocopherol was used as a standard drug. Control was prepared in the similar manner except 
the addition of extract. The degree of glycosylation of hemoglobin in the presence of 
different concentration of extracts and their absence were measured at 520nm using UV 
Visible spectrophotometer.  
 The percentage inhibition was calculated using the following formula; 
% Inhibition =   Abs sample – Abs control   X 100 
                                                                      Abs sample 
 
The results obtained are presented in Table 20 and the graphical representation in Fig. 36. 
 
METHOD 2: INHIBITION OF ALPHA GLUCOSIDASE ENZYME ASSSAY[151,152& 
158-162] 
α-glucosidase inhibitors are used to establish greater nhibitors are used to establish 
greater glycemic control  over  hyperglycemia in  Diabetes type 2 particularly with regard 
to postprandial hyperglycemia. They may be used as monotherapy in conjunction with an 
appropriate diabetic diet and exercise, or they may be used in conjunction with other anti-
diabetic drugs. α-glucosidase inhibitors may also be useful in patients with Diabetes type 2.  
Principle 
Alpha glucosidase inhibitors act as competitive inhibitors of enzymes needed to 
digest carbohydrates specifically α-glucosidase enzymes in the brush border of the small 
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pH 8.0 was added. Then the mixture was incubated for 60min at 35°C. Then the reaction was 
terminated by heat it for 2min in boiling water bath. The amount of liberated glucose is 
measured by glucose oxidation method at 540nm using UV Visible spectrophotometer. 
Acarbose was used as a standard drug. Control was prepared in similar way except extract. 
Distilled water was used a blank. The percentage inhibition was calculated using the formula 
% Inhibition =   Abs sample – Abs control   X 100 
                                           Abs sample 
 
The experiment was carried out in triplicate and the results obtained are presented in Table 
21 and the graphical representation in Fig. 38. 
METHOD 3: INHIBITION OF ALPHA AMYLASE ENZYME ASSAY [150-157] 
 Pancreatic α-amylase belongs to the class of α 1, 4- gluconohydrolases and is one of 
the important target enzymes for the conventional treatment of diabetes. It catalyzes the 
initial step in hydrolysis of starch to maltose and maltotriose which are then acted upon by α-
glucosidases, broken down in to glucose and it enters the blood stream. Naturally available α-
amylase inhibitors from medicinally important plants are shown to be very effective in 
managing post prandial hyperglycemia which is a major concern in type 2 diabetes. 
Principle 
Pancreatic α-amylase is a key enzyme in the digestive system and catalyzes the initial 
step in the hydrolysis of starch, which is a principal source of glucose in the diet. α-amylase 
inhibitors are agents which inhibit the amylase activity  Fig. 39. In which results in the delay 
of carbohydrate digestion and prolong overall carbohydrate digestion time causing reduction 
in the rate of glucose absorption and consequently reducing the post prandial plasma glucose 
rise                                       
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added. Then this solution was incubated for 1h at 37◦C. After incubation, 0.1mL of iodine-
iodide indicator was added. The intensity of the colour was measured at 565nm using UV 
Visible spectrophotometer. 0.1M sodium acetate buffer was used as a blank. The reaction 
without extract was used as a control. Acarbose was used as a standard drug.Inhibition of 
enzyme activity was calculated by using the following formula:  
% Inhibition of enzyme activity =   Abs sample – Abs control   X 100 
                                                                             Abs sample 
The results obtained are presented in Table 22 and the graphical representation is represented 
in Fig. 40. 
METHOD 4: GLUCOSE UPTAKE BY YEAST CELLS [162-168] 
  It is reported that in yeast cells glucose transport is extremely complex and it is 
generally agreed that glucose is transported in yeast is by a facilitated diffusion process. 
Facilitated carriers are specific carriers that transport solutes down the concentration gradient. 
This means that effective transport is only attained if there is removal of intracellular glucose. 
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents  
Baker’s yeast  
Glucose (5 & 10mM) 
Glucose oxidase solution 
Preparation of yeast suspension  
Yeast suspension was prepared according to the method of Cirillo, 1962. 1g of the 
commercial baker’s yeast was washed by repeated centrifugation at 3,000 rpm for 5mi in 
distilled water until the supernatant fluids were clear and a 10% (v/v) suspension was 
prepared in distilled water. 
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Procedure 
Glucose uptake by yeast cells assay was assessed using Manjunatha et al., 2008 with 
slight modification. Various concentrations (40–200µg/mL) of the MECP and MECPAgNPs 
were added to 1mL of glucose solution (5 & 10mM) and incubated together for 10min at 
37°C. The reaction was started by adding 100μL of yeast suspension, vortexed and further 
incubated at 37°C for 60min. After 60min, the tubes were centrifuged at 2,500rpm for 5min. 
To 100µL of glucose oxidase solution, 500µL of supernatant solution was added and kept for 
half an hour at room temperature. Then the percentage increase in glucose uptake by the yeast 
cells was measured at 520nm using a UV visible spectrophotometer. Distilled water was used 
as a blank. Acarbose was taken as standard drug. The reaction without extract was used as 
control. The percentage increase in glucose uptake by yeast cells was calculated using the 
following formula,   
                 Increase in glucose uptake (%) =   Abs sample – Abs control   X 100 
                                                                                      Abs sample 
 
The results obtained are presented in Table 23 and the graphical representation in Fig. 41 & 
42. 
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RESULTS AND DISCUSSION 
 
SECTION A - In-vitro ANTIOXIDANT ACTIVITY 
 The in-vitro antioxidant activity of the methanolic extract of Costus pictus leaves was 
evaluated by five methods. The results obtained for these methods are presented in Tables 15 
to 19 and the graphical representations are presented in Figs. 30 to 34. 
Method I: Free radical Scavenging activity using 2, 2-Diphenyl-1-Picryl hydrazyl 
(DPPH) 
 
The results obtained for the free radical scavenging activity against DPPH radical is 
presented in Table 15 and the graphical representation is presented in Fig. 31 
Table 15: Percentage inhibition of MECP, MECPAgNPs & 
standard ascorbic acid against DPPH at 517nm 
 
S. 
No 
Conc. 
in 
μg/mL 
Percentage 
inhibition by 
ascorbic acid 
Percentage 
inhibition by 
Costus pictus 
percentage 
inhibition by 
Costus pictus 
AgNP's 
1 10 48.91 ± 0.60 35.31±0.115 43.3±0.085 
2 20 48.91 ± 0.60 44.62±0.115 48.71±0.066 
3 40 67.86 ± 0.27 48.64±0.394 60.82±0.085 
4 60 79.49 ± 0.30 60.95±0.167 66.14±0.085 
5 80 85.36 ± 0.29 64.61±0.227 70.23±0.182 
 IC50 27.29 µg/ml 46.66µg/mL 37.64µg/Ml 
*mean of three readings ± SEM 
 
       From the table, it can seen that the MECP, MECPAgNPs showed a percentage 
inhibition of 64.61±0.227 & 70.23±0.182 while ascorbic acid showed a percentage 
inhibition of 85.31±0.29 at a concentration of 80µg/mL.  The IC50 value calculated using 
the linear regression analysis was found to be 46.66, 37.64 and 27.29μg/mL for MECP, 
MECPAgNPs and ascorbic acid respectively (Fig.30). From this, MECPAgNPs showed 
higher antioxidant activity than MECP. The extract possessed a good radical scavenging 
capacity 
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Fig.30: Free radical scavenging of MECP, MECPAgNP’s 
and ascorbic acid  against DPPH at 517nm 
 
 
Method 2: Determination of scavenging activity against hydrogen peroxide  
The results obtained for the scavenging activity against hydrogen peroxide are 
presented in Table 16 and the graphical representation is presented in Fig. 31 
Table16: Percentage inhibition of hydrogen peroxide 
by MECP, MECPAgNPs & standard ascorbic acid 
S. 
No 
Conc. 
in 
μg/Ml 
Percentage 
inhibition by 
ascorbic acid 
Percentage 
inhibition by 
Costus pictus 
percentage 
inhibition by 
Costus pictus 
AgNP's 
1 80 32.44 ± 0.81 23.61±0.35 27.16±0.28 
2 160 35.47 ± 0.91 32.9±0.46 32.17±0.83 
3 240 60.73 ± 0.51 43.45±0.28 45.01±0.43 
4 320 67.32 ± 0.53 64.36±0.33 66.49±0.21 
5 400 79.99 ± 0.51 74.07±0.29 74.56±0.28 
 IC50  221.21 µg/mL  287.14 µg/mL  251.82 µg/mL 
*mean of three readings ± SEM 
 
From the table, it can seen that the MECP, MECPAgNPs showed a percentage 
inhibition of 74.07 ± 0.29 & 74.56 ± 0.28 while ascorbic acid showed a percentage inhibition 
of 79.99 ± 0.51 at a concentration of 400µg/mL. The IC50 value calculated using the linear 
regression analysis was found to be, 287.14, 251.82 and 221.21μg/mL for MECP, 
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MECPAgNPs and ascorbic acid respectively. From this, MECPAgNPs showed higher 
antioxidant activity than MECP. 
Fig. 31:  Scavenging activity by hydrogen peroxide method 
 
 
Method 3: Antioxidant activity by Phosphomolybdenum method 
 
The results obtained for the Phosphomolybdenum activity of MECP, MECPAgNPs 
and standard ascorbic acid are tabulated in Table 17 and the graphical representation is 
presented in Fig. 32 
Table 17: Absorbance of MECP, MECPAgNPs and standard ascorbic acid by 
Phosphomolybdenum method 
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S. 
No. 
Conc. 
in 
µg/mL 
Absorbance of 
Ascorbic acid 
Absorbance of 
Costus pictus 
Absorbance of 
Costus pictus 
AgNP's 
1 16.66 0.085 ± 0.005 0.057±0.003 0.065±0.008 
 2 33.33 0.165 ± 0.004 0.126±0.005 0.138±0.003 
3 50.00 0.206 ± 0.008 0.185±0.006 0.199±0.005 
4 66.66 0.323 ± 0.004 0.28±0.008 0.305±0.005 
5 83.33 0.371 ± 0.005 0.332±0.005 0.355±0.007 
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Fig. 32: Antioxidant activity by Phosphomolybdenum method 
 
 
 
The results obtained for the phosphomplydenum assay are presented in Table 17. 
From the table, it can be seen that the MECP, MECPAgNPs showed an absorbance of 
0.332±0.005 & 0.355±0.007 at a concentration of 100µg/mL while ascorbic acid showed an 
absorbance of 0.371 ± 0.005 at a concentration of 100µg/mL.  The extract shows a dose 
dependent reducing ability. The MECPAgNPs showed higher antioxidant activity than 
MECP. The graphical representations of the phosphomolybdenum assay of the MECP, 
MECPAgNPs and ascorbic acid are presented in Fig. 32. 
Method 4: Ferric Reducing Antioxidant Power (FRAP) Assay  
The results obtained for the Ferric Reducing Antioxidant Power assay are presented in 
Table 18. The graphical representations of the reducing power activity of the MECP, 
MECPAgNPs and ascorbic acid are presented in Fig. 33. 
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Table 18: Ferric reducing anti-oxidant power assay 
of MECP, MECPAgNPs & standard ascorbic acid 
 
S. 
No. 
Conc.  in 
µg/mL 
Absorbance of 
Ascorbic acid 
Absorbance of 
Costus pictus 
Absorbance 
of Costus 
pictus AgNP's 
1 12.5 0.457 ± 0.001 0.36±0.0006 0.38±0.0014 
2 25 0.576 ± 0.004 0.44±0.0017 0.47±0.0060 
3 50 0.667 ± 0.003 0.57±0.0017 0.59±0.0043 
4 75 0.821 ± 0.001 0.72±0.0014 0.76±0.0072 
5 100 0.936 ± 0.002 0.79±0.0011 0.87±0.0020 
    *mean of three readings ± SEM 
From the table, it can be seen that the MECP, MECPAgNPs showed an absorbance of 
0.7 ± 0.0011 and 0.87 ± 0.002 at a concentration of 100µg/mL while ascorbic acid showed an 
absorbance of 0.936 ± 0.002 at a concentration of 100µg/mL. The extract and the 
nanoparticles showed a dose dependent reducing ability. The nanoparticles at the same 
concentration showed much better activity than the extract alone. 
  
 Fig.33: Ferric reducing anti-oxidant assay of MECP &MECPAgNPs 
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Method 5: Reducing Power Assay:  
The results obtained for the Reducing Power assay of MECP, MECPAgNPs and 
standard ascorbic acid are presented in Table 19 and the graphical representation is presented 
in Fig. 34. 
Table 19: Reducing Power Assay of  MECP, MECPAgNPs 
and standard ascorbic acid 
*mean of three readings 
 
 
 
Fig. 34: Antioxidant activity by reducing power assay 
 
 
From the Table 19, it can be seen that the MECP, MECPAgNPs and ascorbic acid 
showed the absorbance of 0.780±0.007, 0.842±0.007 & 1.052±0.007 at a concentration of 
100µg/mL. The MECPAgNPs showed higher antioxidant activity than MECP. 
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S. No. Conc. in µg/mL 
Reducing power 
of Ascorbic acid 
Reducing power  
of Costus pictus 
Reducing power  
of Costus pictus 
AgNP's 
1 20 0.745 ± 0.012 0.340±0.002 0.451±0.005 
2 40 0.820 ± 0.003 0.414±0.004 0.543±0.004 
3 60 0.930 ± 0.002 0.641±0.002 0.702±0.003 
4 80 0.958 ± 0.059 0.689±0.003 0.738±0.005 
5 100 1.052 ± 0.007 0.780±0.007 0.842±0.007 
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SECTION B – In- vitro ANTIDIABETIC ACTIVITY 
METHOD 1: NON ENZYMATIC GLYCOSYLATION OF HAEMOGLOBIN ASSAY 
 The results obtained for the non-enzymatic glycosylation of haemolglobin assay are 
presented in the Table 20 and the graphical representation in Fig. 36. 
Table 20: Non –enzymatic glycosylation of haemolglobin assay 
 
Conc.  
µg/ 
mL 
α-tocopherol MECP MEAgNPs 
Absorbance 
at 520nm* 
% 
Inhibition 
Absorbance 
at 520nm* 
% 
Inhibition 
Absorbance 
at 520nm* 
% 
Inhibition 
200 0.159±0.003 23.19±1.674 0.142±0.001 14.06±0.698 0.148±0.001 20.55±0.643 
400 0.187±0.003 34.84±1.016 0.163±0.003 26.56±0.313 0.191±0.008 35.34±0.328 
600 0.258±0.005 52.68±0.813 0.193±0.008 40.99±0.288 0.22±0.0014 49.62±0.560 
800 0.386±0.004 68.38±0.343 0.323±0.009 60.20±1.015 0.373±0.001 67.31±0.155 
1000 0.512±0.005 76.16±0.215 0.394±0.002 68.08±0.137 0.520±0.006 77.08±0.100 
IC50 600.26 µg/mL 710.71 µg/mL 609.61 µg/mL 
* mean of three readings ±SEM 
From the Table 20, it can be observed that the MECPAgNPs possess very good 
antidiabetic activity as compared to the MECP .The percentage inhibition of glycosylation is 
dose dependent, as dose increases, inhibition increases as shown in the Fig. 36. The 
percentage of inhibition at the concentrations of 200, 400, 600, 800 & 1000 µg/ml by the 
MECPAgNPs and MECP showed a concentration-dependent reduction. The highest 
concentration 1000 µg/ml of MECPAgNPs, MECP and α-tocopherol showed a maximum 
inhibition of 77.08 ± 0.100, 68.0 8± 0.137 & 76.16 ± 0.215 while the lowest concentration 
200µg/mL of MECPAgNPs, MECP and α-tocopherol showed a minimum inhibition of 23.19 
± 1.674, 14.06 ± 0.698 & 20.55 ± 0.693 respectively. The IC50 values of the MECP, 
MECPAgNPs and α-tocopherol were found to be 710.71, 609.01 & 600.26µg/mL 
respectively.  
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Fig. 36: Non - enzymatic glycosylation of haemoglobin assay 
 
 
The plant extracts play an important role in the inhibition of the glycosylation end 
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METHOD 2:  INHIBITION OF ALPHA GLUCOSIDASE ENZYME ASSSAY 
The results obtained for the Inhibition of alpha glucosidase enzyme assay are 
presented in the Table 21 and the graphical representation in Fig. 38. 
              
                         Table 21:  Inhibition of alpha glucosidase enzyme assay 
Conc.  
µg/ 
mL 
Acarbose MECP MEAgNPs 
Absorbance 
at 540nm* 
% 
Inhibition 
Absorbance 
at 540nm* 
% 
Inhibition 
Absorbance 
at 540nm* 
% 
Inhibition 
200 0.801±0.001 25.30±0.20 0.952±0.006 14.54±0.64 0.842±0.004 23.03±0.45 
400 0.521±0.002 51.35±0.19 0.781±0.005 36.60±0.05 0.679±0.001 47.89±0.50 
600 0.381±0.002 64.25±0.22 0.506±0.002 54.51±0.19 0.45±0.0017 62.91±0.17 
800 0.208±0.004 80.53±0.39 0.399±0.008 68.71±0.08 0.345±0.001 78.64±0.29 
1000 0.105±0.002 89.81±0.09 0.204±0.001 79.32±1.95 0.177±0.001 89.47±0.14 
IC50 482.68 µg/mL 596.78 µg/mL 501.34 µg/mL 
            * mean of three readings ±SEM 
 
 
Fig. 38: Inhibition of alpha glucosidase enzyme assay 
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MECPAgNPs and MECP showed a concentration-dependent reduction. The highest 
concentration 1000µg/mL of MECPAgNPs, MECP and acarbose showed a maximum 
inhibition of 89.47±0.142, 79.32±1.954% and 89.81±0.093 while the lowest concentration 
200µg/mL of MECPAgNPs, MECP and Acarbose showed a minimum inhibition of 
25.3±0.197, 14.54±0.64 & 25.3±0.117. Fig.38. MECPAgNPs showed strong α-glucosidase 
inhibition as compared with MECP. The MECP was less potent in inhibiting α-glucosidase as 
compared to acarbose and MECPAgNPs. The IC50 values of the MECP, MECPAgNPs and 
Acarbose were found to be 596.78 µg/mL, 501.34 µg/mL & 482.68 µg/mL respectively.  
α-glucosidase is an enzyme that hydrolyses alpha-bonds of large alpha linked 
polysaccharide and starch to yield glucose. α-glucosidase inhibitors bind to alpha-bond of 
polysaccharide and prevent the breakdown of polysaccharide to glucose. In our experimental 
study it was observed that that MECPAgNPs demonstrated significant α-glucosidase 
inhibition activity as compared to standard drug acarbose. 
METHOD 3:  INHIBITION OF ALPHA AMYLASE ENZYME ASSSAY 
The results obtained for the inhibition of α-amylase enzyme assay are presented in the 
Table 22 and the graphical representation in Fig. 40. 
Table 22:  Inhibition of alpha amylase enzyme assay 
 
Conc.  
µg/ 
mL 
Acarbose 
MECP 
 
MEAgNPs 
Absorbance 
at 565nm* 
% 
Inhibition 
Absorbance 
at 565nm* 
% 
Inhibition 
Absorbance 
at 565nm* 
% 
Inhibition 
200 0.094±0.001 41.44±1.08 0.07±0.0008 28.23±0.83 0.091±0.001 39.89±0.18 
400 0.113±0.003 45.89±1.64 0.094±0.002 40.87±0.45 0.108±0.003 44.77±1.42 
600 0.147±0.001 62.14±0.32 0.124±0.001 55.63±0.41 0.142±0.005 61.26±0.16 
800 0.184±0.002 70.36±0.26 0.134±0.003 59.05±0.10 0.176±0.005 68.71±1.80 
1000 0.224±0.001 74.70±0.58 0.163±0.002 66.37±0.55 0.195±0.002 71.85±0.41 
IC50 513.97µg/Ml 639.83 µg/mL 534.39 µg/mL 
* mean of three readings ±SEM 
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Fig. 40: Inhibition of alpha amylase enzyme assay 
 
 
From the Table 22, it can be observed that the MECPAgNPs possess very good 
antidiabetic activity as compared to the MECP. The in vitro α-amylase inhibition study 
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MECP. The IC50 values of the MECP, MECPAgNPs and acarbose were found to be 639.83, 
534.39 & 513.97µg/mL respectively. 
α-amylase is an enzyme that hydrolyses alpha-bonds of large alpha linked 
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METHOD 4: GLUCOSE UPTAKE BY YEAST CELLS 
a) INHIBITION OF GLUCOSE UPTAKE IN 5mM GLUCOSE 
CONCENTRATION 
The results obtained for the inhibition of glucose uptake in 5mM & 10mM glucose 
concentration assay are presented in the Table 23. The rate of glucose transport across cell 
membrane in yeast cells system was explored and the results are given in Fig. 41. 
                       Table 23: Inhibition of Glucose uptake in 5mM glucose concentration 
Conc.  
µg/ 
mL 
Acarbose 
MECP 
 
MEAgNPs 
Absorbance 
at 520nm* 
% 
Inhibition 
Absorbance 
at 520nm* 
% 
Inhibition 
Absorbance 
at 520nm* 
% 
Inhibition 
40 0.102±0.001 60.78±0.22 0.072±0.006 53.66±0.36 0.086±0.006 58.17±0.44 
80 0.117±0.001 65.81±0.22 0.080±0.008 55.89±0.39 0.096±0.004 63.84±0.18 
120 0.132±0.001 69.70±0.27 0.106±0.008 62.49±0.31 0.125±0.002 67.98±0.24 
160 0.150±0.002 73.33±0.10 0.120±0.007 66.75±0.24 0.148±0.001 73.01±0.35 
200 0.188±0.002 78.72±0.25 0.141±0.001 71.49±0.25 0.186±0.001 77.77±0.43 
IC50 74.08 µg/mL 94.09 µg/mL 78.39 µg/Ml 
* mean of three readings ±SEM 
Fig. 41: Inhibition of glucose uptake at 5mM concentration 
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From the Table 23, it can be seen that the MECP, MECPAgNPs showed a percentage 
inhibition of 71.99±0.246 and 77.77±0.430 while acarbose showed a percentage inhibition of 
78.82±0.248 at a concentration of 200µg/mL. The IC50 value calculated using linear 
regression analysis was found to be 94.09µg/mL, 78.39 and 74.08µg/mL for MECP, 
MECPAgNPs & acarbose. The graphical representation of the inhibition of glucose uptake at 
5mM glucose concentration is presented in the Fig. 41. 
                 Table23. Inhibition of glucose uptake at 10mM concentration 
Conc.  
µg/ 
mL 
Acarbose 
MECP 
 
MEAgNPs 
Absorbance 
at 520nm* 
% 
Inhibition 
Absorbance 
at 520nm* 
% 
Inhibition 
Absorbance 
at 520nm* 
% 
Inhibition 
40 0.200 ± 0.003 65.00±0.24 0.166±0.001 57.07±0.44 0.190±0.008 63.21±0.17 
80 0.214 ± 0.002 67.28±0.16 0.198±0.001 60.64±0.18 0.206±0.003 66.05±0.52 
120 0.249 ± 0.004 71.88±0.18 0.213±0.001 65.12±0.24 0.229±0.004 71.49±0.55 
160 0.303 ± 0.003 76.89±0.21 0.241±0.001 70.91±0.35 0.295±0.003 76.28±0.27 
200 0.379 ± 0.001 81.53±0.18 0.267±0.003 74.96±0.79 0.373±0.002 81.24±0.12 
IC50 67.40 µg/mL 84.26 µg/mL 69.87 µg/mL 
                                    * mean of three readings ±SEM 
                     
Fig. 42: Inhibition of glucose uptake at 10mM concentration 
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From the Table 23, it can be seen that the MECP, MECPAgNPs showed a percentage 
inhibition of 74.96±0.791 and 81.24±0.120 while acarbose showed a percentage inhibition of 
81.53±0.181 at a concentration of 200µg/mL. The IC50 value calculated using linear 
regression analysis was found to be 84.26µg/mL, 69.37 µg/mL and 67.40µg/mL for MECP, 
MECPAgNPs & acarbose respectively. The graphical representation of the Inhibition of 
Glucose uptake in 10Mm glucose concentration was presented in the Fig. 42. 
After the treatment of the yeast cells with the MECP, MECPAgNPs the glucose 
uptake was found to increase in a dose dependent manner. The amount of glucose lingering in 
the medium after a specific time serves as a marker of the glucose uptake by the yeast cells. 
The rate of uptake of glucose into yeast cells was linear in the 5mM & 10mM glucose 
concentrations. Results indicated that MECPAgNPs had greater efficiency in increasing the 
glucose uptake by yeast cells as compared to MECP in both 5mM & 10mM glucose 
concentrations 
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CHAPTER 9 
SUMMARY AND CONCLUSION 
 
The dissertation entitled “Green synthesis of silver nanoparticles from the 
methanolic leaf extract ofCostuspictus D. Don (Costaceae) for enhancing the oral bio-
availabilty and its anti-diabetic activity “. 
The chapter on Review of literature of the plant Costuspictus D. Don (Costaceae) 
provides information on the pharmacognosy, phytochemical, and pharmacological activities 
of the various species of Costus. It also reveals the synthesis of silver nanoparticles from 
various extract of the plants. 
The chapter Pharmacognostical Evaluation describes the macroscopical, 
microscopical studies, standardization parameters, quantitative microscopy, cell 
morphological characters, powder microscopy of the leaves. The following features are 
observed for this plant. 
 It is an erect herb growing up to 3meters tall; the stem is horizontally striped at 
base. The leaves are narrowly lanceolate, dark green above and lighter green 
below, small leaves are present on the basal part, bract green, with outer 
margin coloured maroon. Flowers are yellow, lip with maroon striations, 
darker yellow stripe down the middle region, anther cream coloured. 
 The vascular bundles of the lamina occur in a single horizontal row of the 
median part of the lamina. The wide circular xylem elements and thick cluster 
of phloem and parenchymatous bundle sheath. 
 The adaxial epidermis is thick and it consisting of narrow tubular cells. The 
abaxial epidermis is apostomatic. The abaxial epidermis is stomatiferous. 
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 The stomata are diffuse in distribution. They are surrounded by two pairs of 
subsidiary cells and one pair of polar subsidiary cells. This type of stomata is 
called hexacytic stomata. 
 Calcium oxalate crystals of minute particle are aggregated in to larger masses 
in the leaf mesophyll cells.The crystals located in ordinary unspecialized cells.  
These characters play an important role in the authentication of crude drug and will 
also be useful for the detection of adulteration. 
 Quantitative analytical microscopy, powder analysis and standardization 
parameters, evaluation gives values which are constant and will be useful for 
the identification for its quality and purity, authentication of the crude drug 
and the plant material.  
 The chapter Synthesis of Costuspictus D. Don silver nanoparticles focuses mainly 
on green route for the synthesis of nanoparticles.  For a long time, herbal medicines were not 
considered for development as novel formulations owing to lack of scientific justification and 
processing difficulties, such as standardization, extraction and identification of individual 
drug components in complex polyherbal systems. However, modern phytopharmaceutical 
research can solve the scientific needs (such as determination of pharmacokinetics, 
mechanism of action, site of action, accurate dose required etc.) of herbal medicines to be 
incorporated in novel drug delivery system, such as nanoparticles, microemulsions, matrix 
systems, solid dispersions, liposomes, solid lipid nanoparticles and so on.  
 The biological synthesis of silver nanoparticles usingCostuspictus extract was 
shown to be rapid and produced particles of fairly uniform size and shape. As 
the methanolic leaf extracts of CostuspictusD. Don were mixed with the 
aqueous solution of silver ion complex, it changed into brown colour due to 
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the excitation of surface Plasmon vibrations, which indicated the formation of 
MECPAgNPs.  
 The nanoparticles were primarily characterized by UV-Visible spectroscopy, 
which was proved to be very useful technique for the analysis of 
nanoparticles. In the UV-Visible spectrum, the broadening of the peak 
indicated the particles are poly dispersed. The surface Plasmon band in the 
silver nanoparticles in the solution remains close to 420nm. Throughout the 
reaction period indicating the particles are dispersed in the aqueous solution of 
silver nitrate, with no evidence for aggregation. The average particle size (z- 
average) was found to be 132.6nm, its polydispersity index was 0.248 and zeta 
values were measured and found to -25.1mV with the peak area of 100% 
intensity. This indicates that the silver nanoparticle formed is stable.  
 A SEM images showed that the silver nanoparticles formed were spherical in 
shape, with an average size of around 100nm. SEM showed uniformly 
distributed silver nanoparticles on the surface of the cells was observed.    
This green chemistry approach towards the synthesis of silver nanoparticles has many 
advantages such as, ease with which the process can be scaled up, economic viability, etc.  
The chapter on Phytochemical Evaluation deals with the preliminary phytochemical 
evaluation and quantitative estimation of phytoconstituents present in the methanolic extract 
of the plant which gives information on the identify the presence of the secondary metabolites 
present inCostuspictus D. Don. The amount of vitamin C, phenols, tannins and flavonoid 
content of MECP and MECPAgNPs was compared. These determination and quantification 
gives the information about the amount of secondary metabolites present in the MECPAgNPs 
was higher than the MECP which is responsible for the therapeutic or pharmacological 
activity of the plant.  
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The chromatographic studies of the plant which includes TLC and HPTLC fingerprint 
profile was carried out. The MECP was subjected to TLC. The presence of quercetin was 
confirmed by HPTLC. 
The chapter Pharmacological Evaluation deals with the comparision of 
MECPAgNPs and MECP for its in vitro anti oxidant and in vitro antidiabetic activity. 
 The antioxidant activity of MECPAgNPs and MECP have exhibited radical 
scavenging activity by DPPH assay, hydrogen peroxide, FRAB, Reducing 
power assay, Phosphomolydenum method shown potent anti oxidant activity. 
The MECPAgNPs showed very potent anti oxidant activity as compared to 
MECP. 
 The in vitro antidiabetic activity of MECP &MECPAgNPs was screened by 
4 methods namely,  
i) Non- enzymatic glycosylation of haemoglobin assay. 
ii) Alpha Glucosidase inhibition assay 
iii) Alpha amylase inhibition assay 
iv) Glucose uptake by Yeast cells 
The MECPAgNPs& MECP displayed the inhibition of haemoglobin glycosylation 
concentration of glucose over the period of 72hrs, indicating that the MECPAgNPs& MECP 
decreases the formation of the glucose- haemoglobin complex and thus the amount of free 
haemglobin increases.MECPAgNPs exhibited higher inhibition of glycosylation as compared 
with the MECP at a concentration of 200-1000µg/mL. 
In alpha amylase enzyme inhibition assay and alpha glucosidase enzyme inhibition 
assay, the results showed MECPAgNPs had efficiently inhibits both alpha amylase, alpha 
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glucosidase enzyme, in vitro in dose dependent manner than MECP at a concentration of 
200-1000µg/mL. 
MECPAgNPs had greater efficiency in increasing the glucose uptake by yeast cells as 
compared to MECP at a concentration of 200-1000µg/mL. 
Antidiabetic activity ofCostuspictus D. Don might be due to the presence of 
pentacyclictriterpene compound such as β- amyrin and β- L- Arabinopyranose methyl 
glucoside in the plant.[78] 
Many in vivo and in vitro studies of this Insulin plant are carried out showed that this 
plant is having very potent antidiabetic effect. Though being widely used, no formulation 
containing this plant is available in the market.  The patient feels difficulty in chewing the 
leaves for a month. In order to overcome this and to enhance the oral bio-availability & 
pharmacological activity, protection from toxicity, physio-chemical degradation, improved 
tissue macrophages, to avoid repeated administration of the dose and to achieve the selective 
or targeted drug delivery towards a specific tissue or organ a attempt is made in this study to 
synthesis MECPAgNPs. 
In an attempt to find natural, environmentally benign, easily available plant- based 
agents for the synthesis of metal nanoparticles, we have demonstrated the efiiciency 
ofCostuspictus D. Don leaf extract in the rapid synthesis of silver nanoparticles possessing a 
variety of fascinating morphologies owing to its diverse groups of phytochemicals like 
phenols, flavonoids, reducing sugars, sterols.  
Silver nanoparticles synthesized from MECP showed higher antidiabetic activity as 
compared to the MECP.MECPAgNPsenhances the dissolution rate by increasing the 
absorption due to decreasing the particle size (132.6nm) and hence results in increased oral 
bioavailability. 
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It can be concluded that the leaves of Costuspictus D. Don can be a good source for 
synthesis of silver nanoparticle which shows potent anti oxidant and antidiabetic activity than 
the MECP. The important outcome of the study will be the development of value added 
product from medicinal plant Costuspictus D. Don for biomedical and nanotechnology based 
industries. Overall, thisapproach seems to be one of the best strategies for therapeutic 
management to treat diabetics. 
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